Brief CV for James W. Cooper, Jr. (706) 769-7586 and Fax) Address: UGa College of Rx 1200 Collliers Creek Rd. Watkinsville GA,30677-1867 [email protected] web sites www.cooperconsultantpress.com. Education:B.S. Pharmacy ('68) and Ph.D. in Pharmaceutical Sciences and Clinical Pharmacy ('72) at UGa Licenses: Georgia No. 9725; Rhode Island No. 2186 Certification: Board Certified Pharmacotherapy Specialist (BCPS), 1993-2000, re-certified 2000-2007 &2007-2014; certified geriatric pharmacist (CGP), 1998-2009. Present Positions: President, Consultant Press, Director of Education and Research, SHCA, and Emeritus Albert W. Jowdy Professor of Pharmacy Care, College of Pharmacy, and formerly Honors, Graduate and Gerontology Faculties of the University of Georgia; formerly Assistant Clinical Professor, Department of Family Medicine, School of Medicine, The Medical College of Georgia at www.mcg.edu now Georgia Health Sciences University; past positions- founding Department Head, Department of Pharmacy Practice, UGa, 1980-1992, Assistant Dean for External Affiliations, UGa, 1992-4, Associate Professor and Director of Clinical Pharmacy, College of Pharmacy, University of Rhode Island, 1972- 76. Clinical Services-Admission and monthly drug therapy evaluation of selected personal care, assisted living and nursing home patients; prn consultation to Adult Day Care, Alzheimers and Parkinson Support Groups, home and hospice care patients. Offer consultative services to any religious group, pharmacist or other health care provider or patient/family/caregiver who calls/writes/e-mail. Past services to 4 hospitals and 11 nursing homes, one primary care center, home health and hospice agency. Served over 6,000 patients at all levels of care. Instructional- Developed and/or taught in 70 courses in B.S., M.S.,Pharm.D., Ph.D. to over 4,000 pharmacy, nursing, gerontology, social work, public health and medical students and Post-Doctoral (Ph.D., Pharm.D. and M.D.) Fellowship and Residency Programs at URI/Brown U. School of Medicine and UGa/MCG Editor: NCPA Regimen 1990-2003, Clinical Consult ASCP, 1980- 1992 ;Current Editorial Advisory Boards-Annals of Long-Term Care: Clinical Aspects of Aging, The Consultant
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Brief CV for James W. Cooper, Jr. (706) 769-7586 and Fax) Address: UGa College of Rx 1200 Collliers Creek Rd. Watkinsville GA,30677-1867 [email protected] web sites www.cooperconsultantpress.com. Education:B.S. Pharmacy ('68) and Ph.D. in Pharmaceutical Sciences and Clinical Pharmacy ('72) at UGa Licenses: Georgia No. 9725; Rhode Island No. 2186 Certification: Board Certified Pharmacotherapy Specialist (BCPS), 1993-2000, re-certified 2000-2007 &2007-2014; certified geriatric pharmacist (CGP), 1998-2009. Present Positions: President, Consultant Press, Director of Education and Research, SHCA, and Emeritus Albert W. Jowdy Professor of Pharmacy Care, College of Pharmacy, and formerly Honors, Graduate and Gerontology Faculties of the University of Georgia; formerly Assistant Clinical Professor, Department of Family Medicine, School of Medicine, The Medical College of Georgia at www.mcg.edu now Georgia Health Sciences University; past positions- founding Department Head, Department of Pharmacy Practice, UGa, 1980-1992, Assistant Dean for External Affiliations, UGa, 1992-4, Associate Professor and Director of Clinical Pharmacy, College of Pharmacy, University of Rhode Island, 1972- 76. Clinical Services-Admission and monthly drug therapy evaluation of selected personal care, assisted living and nursing home patients; prn consultation to Adult Day Care, Alzheimers and Parkinson Support Groups, home and hospice care patients. Offer consultative services to any religious group, pharmacist or other health care provider or patient/family/caregiver who calls/writes/e-mail. Past services to 4 hospitals and 11 nursing homes, one primary care center, home health and hospice agency. Served over 6,000 patients at all levels of care. Instructional- Developed and/or taught in 70 courses in B.S., M.S.,Pharm.D., Ph.D. to over 4,000 pharmacy, nursing, gerontology, social work, public health and medical students and Post-Doctoral (Ph.D., Pharm.D. and M.D.) Fellowship and Residency Programs at URI/Brown U. School of Medicine and UGa/MCG Editor: NCPA Regimen 1990-2003, Clinical Consult ASCP, 1980- 1992 ;Current Editorial Advisory Boards-Annals of Long-Term Care: Clinical Aspects of Aging, The Consultant
Pharmacist.Formerly- Commission on Geriatric Pharmacy 2011- and the American Journal of Geriatric Pharmacotherapy Reviewer: 45 publications (see list in full version) Founding and Emeritus Editor: Journal of Geriatric Drug Therapy, 1984-1999. Fellow: American College of Clinical Pharmacology (1979-) ; American Society of Consultant Pharmacists(l989-), American Society of Hospital Pharmacists (1992-) Current Member: American Society of Consultant Pharmacists, Former member-American College of Clinical Pharmacy, American Geriatrics Society, Georgia Pharmacists Association, Georgia Society of Consultant Pharmacists, American Medical Directors Association (affiliate member). Publications: 35 books/manuals/monographs, 19 chapters, 303 professional papers, 32 book reviews, 120 research papers, and 173 presentation abstracts, primarily on geriatric drug therapy. Research Interests- Geriatric Drug Therapy Efficacy,Toxicity, Pharmacoeconomics, Pharmacoepidemiology and Pharmacist Effect on Drug-Related Problems and Disease Management in the Older Adult. Research projects: 15 graduate students, 4 post-docs, one honors baccaluareate thesis and 72 undergraduate research projects with over 200 students. Currently: projects on falls, osteoporosis, pain management and NSAID interventions, Presentations: Over 1,500 to 46 states and 7 countries.Visiting Professorships to U. of Florida, Tennessee, Mercer, Samford and South U. and in Canada to U. of Manitoba (2X), Spain (4X), England, Scotland and Korea. Funding (Teaching, service and research)->$1,500,000Honors-AFPE Scholarship, NSF Trainee(’69-’72), White House Conference on Aging Advisor ('81), Archambault Award(ASCP'82), ASHP Research and Education Foundation(REF) Award for Hospital Pharmacy Practice('78),ASHPAward for Sustained Contributions to the Literature of Hospital Pharmacy('90), Fulbright Lectureship (declined,'84),Brookdale Award in Gerontology Nomination by ASHP and ASCP('81&'82), four national ASCP paper awards, Creative Research('85) and McNeil Clinical Research Awards('87) at UGa. First Peter P. Lamy Memorial Lecture Presenter, ASCP, 1999, Pinnacle Award APhA and HCQA, 2000, USP Gerontology Expert Committee, 2000-2005, Teacher of The Year, UGa College of Pharmacy, 2001 and 2006, Dedication of the Georgia Pharmacist Magazine for 2001, Appointed to CGP Credentialing and Exam Committee, 2002-2005. Honored with Member Profile in The Credential of CCGP Vol. 4, no. 4, 2001, Albert W. Jowdy Chair of Pharmacy Care,
2001-2003, Emeritus Professor of Pharmacy, 2003-passing. Part-time (0.49FTE) UGa Nov 2003-.December 2007. ASCP Leadership in Education Award, 2009, named lifetime Fellow of ASCP, 2013. 2013
Brief Biosketch Dr.Jim Cooper practices, teaches in on-line, classroom and clinical
settings and conducts research on geriatric pharmacotherapy in ambulatory and long-term care settings formerly at the University of Georgia and now on-line around the southeast. He has taught infectious disease and oncology therapeutics and nine electives,and gives selected lectures in other therapeutics courses, research in nursing course and developed 70 courses. Consultant pharmacy services, as well as teaching and research bases have included a 170-bed teaching skilled facility, nine other nursing facilities, 100+-client adult day-care and several personal care homes. He also provides a medication evaluation and long-term care counseling service for seniors in his church and the community-at-large. Jim has authored 35 books, manual and monographs, 19 book chapters, 330 professional and 115 research papers and 172 abstracts, and given over 1,800 invited presentations, primarily on geriatric drug therapy in 46 of 50 states and been a visiting professor in Canada, the UK, Spain and Korea, as well as seven universities in the USA. He has served over 4,000 students, residents and fellows in pharmacy, medicine and nursing and more than 6,000 patients at all levels of care.
Curriculum Vitae 2013
James Weaver Cooper, Jr. Office ADDRESS: Home Office-1200 Colliers Creek Road, Watkinsville, Georgia 30677-1867 PHONE:(706) 769-7586 and College of Pharmacy, University of Georgia at home address. E-mail: [email protected] web site: www.cooperconsultantpress.com. EDUCATION: Primary/Secondary: Louisville, Kentucky; Baltimore, Maryland and Savannah, Georgia public and private schools. High School: HV Jenkins, Savannah, 1960 Colleges: Furman University, 1960-61, pre-engineering, track scholarship; United States Military Academy, West Point, NY, 1961; University of Florida, 1963, chemical engineering, track scholarship; Armstrong State College, 1964-65, pre-pharmacy, UGa as below DEGREES: B.S. Pharmacy, cum laude, University of Georgia, June, 1968 Ph.D., Pharmaceutical Sciences, University of Georgia, August, 1972 (Biopharmaceutics) (Major Professors-Dr. H.C. Ansel; Dr. D.E. Cadwallader) Minors: Biochemistry, Physical Chemistry and Clinical Pharmacy, Preceptor: Dr. Leslie Hendeles CERTIFICATION: Board of Pharmaceutical Specialties, Board Certified Pharmacotherapy Specialist (BCPS), 1993-2000 and re-certification, 2000-2007 and 2007-2014. Commission for Certification in Geriatric Pharmacy, Certified Geriatric Pharmacist (CGP), 1998-2008. Fellow: American College of Clinical Pharmacology (1979-Lifetime); American Society of Consultant Pharmacists (l989-Lifetime), American Society of Hospital Pharmacists (1992- Lifetime) POST-GRADUATE TRAINING: 1973 - Albany College of Pharmacy Clinical Fellowship, 80 contact hours;1985 - Eastern Virginia Medical School Geriatrics Course- 9 CMEs; 1987 - Consultant Pharmacist, UGa. 1.6 C.E.U.;1988 - Peoples Law School - Georgia Trial Lawyers Association, 24 hrs.; 1988 - Harvard Medical School, Geriatric Medicine Review - 30 CMEs;1988-92 University of the South, School of Theology, Education for Ministry, 330 contact hrs 1988-1994.;1990 - The Georgia Executive Program, College of Business, UGa May 1990;1992 and 93-University of The South, School of Theology, Mentor Training, June 1992, 18 hours; 1991- Oschner Antibiotic Lecture Series, LaJolla, 12 hrs.; 1992- U. of Tennessee-Indian Health Service-Certified Patient Education Facilitator Phase I and 1993, Phase II, 15 hours each;1992-Infectious Disease Challenges in Primary Care, Oak Park
Hill, Il, 12 hours; 1991-93 Pharmacotherapy Self-Assessment Program (PSAPI) 110 hours, 1st ed.; Distinguished Faculty in Anxiety Conference, Palm Springs, CA, March, 1995, 12 hours; Distinguished Faculty in Depressive Disorders, Phoenix, AZ, March, 1995, 12 hours; PSAP II, American College of Clinical Pharmacy, 1995-1997, 195 hours. National Endocrinology Consultants Initiative, 1997.ACCP Pharmacoeconomics and Outcomes: Applications for Patient care Self-Study Course, 1998-2001, PSAP III 1998-2000., PSAP IV -3 -
2001-2003, 180 hrs. PSAP V 2003-2006, 192 hrs. Re-certified for BCPS, 2007-2014. 377 total hours. Developed 146 contact hours of CPE/CNE/CME credit past 8 years. MILITARY SERVICE : Honor Guard, State of South Carolina, 1961 Inaugural Parade of President John F. Kennedy (Furman ROTC);USMA, 1961; United State Military Academy, 1961; Acting E-7 (drill Sergeant), Fort Jackson SC Basic training and Cuban Missile Crisis, 1962, U.S. Army Reserve (USAR), 1961-1967, Veteran, E-4, Honorable Discharge, 13th Special Forces Group (Airborne) Vietnam Era veteran. Army Pre-Commissioning Course (450 hours) 1964. EXPERIENCE: Professional (P/T=part-time) Hospital- Athens General Hospital, Athens, Georgia (1969-72) (P/T) Univ.of Georgia, Health Services Pharmacy (1969-72) (P/T) St. Joseph's Hospital, Providence, Rhode Island (1972-1976),Director of Clinical Pharmacy Education Miriam Hospital - Director of Clinical Pharmacy Education, Providence, Rhode Island (1973-76). St. Mary's Hospital, Athens, Georgia, Consultant Staff, 1976-1981. Athens Regional Medical Center, Athens, Georgia, Consultant/Staff, January, 1977-1990. Wellspring Alcohol and Drug Treatment Center, Athens, Georgia, Director of Pharmacy Services and clinician counselor, 1977-78. BJC Medical Center and Nursing Facility Consultant,1979-2004. Community:- Independent-Hodgson's Pharmacy , Athens, GA Internship, 1968-9 & Consultant, 2000- Citizens Pharmacy, 1970-72 (P/T), Chain - King Discount, Athens, GA - 1969-71 (P/T) Apothecary - Wellins Pharmacy, Warwick,RI 1974-6, (P/T) and 7 nursing homes, research Consultant, Athens Council on Aging, Senior Citizens Center, 1993-1995 Consultant, Athens Adult Care Center, 1992-1998.
Consultant, Iris Place (independent living older adults), 2000-2001 Consultant and Lecturer on Safe Medication Use in Older Adults, UGa OLLI Learning in Retirement program 2006-2013 and 7 area churches and synagogue, Nursing Home - Athens Health Care Center Inc. Assoc. Director of Pharmacy Services, and Consultant Pharmacist, 1976-91. BJC Medical Center Nursing Home-Consultant Pharmacist, 1979-2004. Eldercare LTC Pharmacy- State of Georgia, 2003-2008 clinical outcomes research School - Director of Pharmacy, College of Pharmacy, UGa, 1989-1992. Medical- Member, Adjunct Medical Staff, Miriam Hospital (1973-76). Member, Dept.of Anesthesiology, St. Joseph's Hospital (1972-76). Consultant to the Medical Staff, Rhode Island State Hospital (1976). Consultant to Northeast Georgia Area Physicians, 1976-present -4 -
Academic- Teaching Assistant, Pharmacy and Pharmacology Labs, School of Pharmacy, University of Georgia (UGa) (1969-1972). Instructor, Clinical Pharmacy Clerkship and Seminars, School of Pharmacy, UGa (1972). Assistant Professor and Coordinator of Clinical Pharmacy, College of Pharmacy, University of Rhode Island (1972-75); Director,(1975-76). Instructor for St. Joseph's Hospital, Our Lady of Providence and Our Lady of Fatima units clinical pharmacy course (1972-75). Instructor for Medical Education Drug Lecture Series of St.Joseph's Hospital to physicians, pharmacists, anesthetists and nurses (1972-74). Dermatology Residency Faculty, Roger Williams Hospital, Providence, RI and Brown Medical Sciences Program, (l974-75). Allergy Residency Faculty, Rhode Island Hospital and Brown Medical Sciences Program, Providence, RI, (l973-76). Assistant Professor and Coordinator of Clinical Pharmacy, School of Pharmacy, UGa (1976-78). Director, Pharmacy Practice Program, University of Georgia School of Pharmacy (1977-79). Faculty of Gerontology, University of Georgia (1977-). Assistant Clinical Professor of Medicine, Department of Family Practice, Medical College of Georgia (April 1978-). Associate Professor of Clinical Pharmacy (1978-1983) (with Tenure) UGa. Honors Faculty, University of Georgia (1978-). Graduate Faculty, University of Georgia (1978-). Founding Head, Department of Pharmacy Practice (1980-1992).
Professor of Pharmacy Practice (1983-1997). Visiting Professor, University of Florida, 1990. Post Grad-2008- Visiting Professor, University of Tennessee, 1992. Visiting Professor, University of Manitoba and Manitoba Pharmacists Association, 1993 and 1994. Visiting Professor, Colegio de Farmaceuticos, Alicante, Spain, 1987, 1989, 1992, and Universities of Valencia, Alicante, Cordoba, Granada and Seville, 1994 Assistant Dean for External Affiliations, College of Pharmacy, University of Georgia (1992-94). Visiting Professor, University of Bristol Royal Health Care Trust, 1992. Professor of Clinical and Administrative Sciences (1998-), Sciences changed to Pharmacy, 2002 Visiting Professor via Extension/Internet, McWhorter School of Pharmacy, Samford University, 1999-2003 Visiting Professor via External PharmD program shared with UGa, Mercer University, Southern School of Pharmacy, 2002-2006. Visiting Lecturer to South University School of Pharmacy, 2005. Albert W. Jowdy Professor of Pharmacy Care, 2002-2003. Emeritus Professor of Pharmacy,2003 until passing. P/T (0.49 FTE) UGa 11/03-12/07. -5 -
Visiting Lecturer to UNC-Charlotte School of Nursing, 2010- Instructional Material Developed and Current Course Involvement: Courses, Baccalaureate*, Graduate** and Doctor of Pharmacy***. 1. PHR 321 , 406 , 407 , 408 (Lab) Preparations and Compounding Technology (UGa),1969-72.* 2. PHR 58l (Lab) Pharmacology (UGA), 1971.* 3. PHC 371 Introduction to Clinical Pharmacy (URI), 1976.* 4. PHC 399 Pharmacy Externship (URI), 1975-76.* 5. PHC 451 Clinical Pharmacy Orientation (URI), 1972-76.* 6. PHC 499 Clinical Practicum (URI), 1973-76.* 7. PHC 552 Advanced Clinical Practicum (URI) (MS/PhD),1974.** 8. PHR 570 Clinical Clerkship (UGA), 1972, 1976-88.* 9. PHR 503 Clinical Conference (UGA), 1976-82.* 10. PHR 524 /724 Advanced Institutional Pharmacy (UGa),1976-80.*/** 11. PHR 537 Introduction to Institutional/Clinical Pharmacy (UGa),1976-80.* 12. PHR 560 /760 Clinical Seminar (Selected Lectures) (UGa),1976-93.*/** 13. PHR 770 Advanced Clinical Clerkship (Masters) (UGa),1976-80.** 14. PHR 570A Clinical Clerkship (Geriatrics) (UGa),1977-78.* 15. PHR 570B Clinical Clerkship (General Medicine) (UGa),1976-78.* 16. PHR 826 Clinical Pharmacokinetics (Selected Lectures)(UGa), 1977.** 17. PHR 500 Clinical Externship (UGa), 1976-1980.* 18. PHR 585 Therapeutics (UGA), 1977-1996, Coordinator,1990-1996.* 19. PHC 498 Special Problems (URI), 1972-6.* 20. PHC 599 M.S. Research (URI), l976-7.** 21. PHC 699, Ph.D. Research (URI), 1976-7.** 22. PHR 930 Thesis (UGA), 1976-.**
23. PHR 780X Geripharmacotherapeutics (UGA), 1979.** 24. PHR 785-6 Advanced Therapeutics (UGA), 1979-80.** 25. PHR 803 Graduate Seminar (UGA), 1980.** 26. PHR 574 Pharmacy Practice Problem Solving I (UGA),1981-82.*** 27. PHR 576 Pharmacy Practice Problem Solving II (UGA),198l-82.*** 28. PHR 400 Drug Information (UGA), 1982.* 29. PHR 540 Patient Assessment (UGA), 1982.* 30. PHR 577 , 578 , 579 Doctor of Pharmacy Project, 1982-3.*** 31. PHR 538 Drug-Related Problems 1980-89., Selected lectures, 1990-* 32. PHR 551 Health Care Seminar 1984-90.*** 33. PHR 555 Clinical Conference 1982-84.*** 34. PHR 571 Advanced Clerkship (Geriatrics) 1984-88.*** 35. PHR 500D Geriatric Clerkship, B.S. program (l985-1997 ).* 36. PHR 310 Orientation to Pharmacy Practice 1981-88.* 37. PHR 437 Dispensing (5 lectures) 1982-89.* 38. GER 600 Gerontology Symposium 1987.** -6 -
39. PHR 554b Applied Pharmacokinetics (lect.) 1988-90.*** 40. PHR 562a Pathophysiology (lect.) 1988-89*** 41. PHR 587 Adv.Pharmacotherapy & Pathophysiology (lect.)1989-91.*** 42.-5. PHR 521Special Topics:Self Instructional Courses in Oncology, Immmunotherapy, Interpretation of Lab Tests and Case Studies in Pharmacy Practice 1993-. */*** 46. PHR 572D/573- Pharm.D. required and elective clerkships,1992-1997.*** 47. PHR 521, Self-Study in Infectious Disease Case Studies Elective,1996-8*, *** 48. PHRM 4180, Infectious Diseases, Co-coordinator and lecturer,33%*,1996-*** 49. PHRM 4190, Cancer Therapy ,Co-coordinator and lecturer, 50%, 1996-*** 50. PHRM 5140 Problem-Based Learning, co-facilitator, 1997-2000.*** 51. PHRM 5920, Clinical Conference, Advisor, 1997- , Coordinator Fall Semester,1998- 52. PHRM 5870- Pharmacotherapy II (lectures), 1997-*** 53. PHRM 3110- Client Visitation and Case Presentations, 1998-*** 54. PHRM 4120- Patient Counseling, 1998-*** 55. PHRM 5900- Pharm.D.Geriatrics Clerkship, 1992-*** 56. PHRM 4850- Disease State Management, (lectures) 1999-*** 57. PHRM 5860- Pharmacotherapy I (lectures), 1999-*** 58. PHRM 5870- Pharmacotherapy II (lectures), 1998-*** 59. PHRM 8610- Health Care Systems (lecture), 1998-*** 60. PHRM 5650- Pharmacy Care Management (advisor), 1999-*** 61.PHRM 5840, Physical Assessment (lab instructor) 1991-*** 62. PHRM 3750- Health Care Systems (lecture), ***, 2001- 63. PHRM 3940- Survey of drug information (lectures),***2001- 64. PHRM 5060 Oncology Therapeutics*** (elective) 2002- 65. PHRM 5070 Immunotherapy *** (elective) 2002- 66. PHRM 5090 Infectious Disease Case Studies *** (elective) 2002- 67. PHRM 5340-Consultant Geriatric Pharmacy (elective) 2006-. 68. PHRM 5360-Geriatric Drug Therapy Intervention and Guide (elective). 2006- 69. PHRM 5210- Lab tests and associated physical assessment for drug therapy, 2007-
70. Nursing Research and Practice Courses, UNC- Charlotte (lectures) 2010- Special Instructional Material Developed: 1. Process Guide to Clinical Orientation for Pharmacy Student/Staff, 1980. 2. Patient Medication History Procedure. 3. Patient Monitoring Guide for Long-Term Care Patients.1980, 1984 and 1986 editions. 4. Patient Counseling Guide, 1985. 5. Pharmacokinetic Dosing of Aminoglycosides and Digoxin,1986. 6. Consultant Pharmacist Certificate Program, 1990 and 1993 editions."Geriatric Medication Management" through California Pharmacists Association 7. Self-study electives in oncology, immunology, infectious disease and geriatrics, Safe medication use for older adults and Omnicare Guidelines-1997-2008. 8. Certified Geriatric Pharmacist Exam Preparation Course- 2003-5 9. Consultant Pharmacist Certificate Course One (20 hrs.) 2010-see 10. for source -7 -
10. Geriatric Pharmacist Certificate Course Two-Medication Therapy Management (30 hrs) 2013 available on www.cooperconsultantpress.com. With Dr. Burfield 11. Lab Tests and Physical Assessment of Drug Therapy In the Older Adult- 2012 at http://cpe.pharmacy.ufl.edu/ for 15 CPE hours (1.5 CEU) with Dr. Burfield 12. Get Smart(er): Know Your Antibiotics & Vaccines-A Basic Primer for Pharmacists - 2013 for 12 hours CPE at http://cpe.pharmacy.ufl.edu/. Used to certify Florida pharmacists for immunization administration. 13. Consultant Pharmacy and Long Term Care Patients-Self Study Course-2013 for 12 hours CPE at http://cpe.pharmacy.ufl.edu/ 14. Minimizing the Risk of Polypharmacy in the Older Adult-in development at UFl with Dr. Burfield. Committees- National American College of Clinical Pharmacy, Reviewer, Statement on Geriatric Drug Use,1998, PSAP Reviewer, 2000- American Pharmaceutical Association, Drug Control Systems in Long Term Care, 1976- 79; Academy of Pharmacy Practice; Section on Long term Care. 1972-1979, Chair, 1974-1975 American Society of Hospital Pharmacists, Panel on Student Membership, 1976- 88;Geriatric Fellowship Selection Committee, 1995. Health Services Adm. DHEW-Committee on Needs of the Geriatric Patient, 1978-9. Advisory Panel on DHEW Surveyor Stds. for Long-Term Care Facilities,1978-86. National Institutes of Health, Consultant File 1979-. American Association of Colleges of Pharmacy Task Force on Aging, 1979-81. American Society of Consultant Pharmacists Council on Education, Chair,1982-85; Planning Council on Mission Statement, 1989;Grant Selection Committee Chair 1991, 1992;Meeting Planning Committee, 1993; Geriatric Fellowship Committee,1995; Geriatric Review Course Advisory Board, 2011- Bureau of Health Professions, HRSA, USDHHS Advisory Panel on National Geriatric Education Conference, 1985-6.
Department of Health and Human Services, Delaware Valley Geriatric Education Center Review Panel, 1987. University of Colorado Health Sciences Center, Geriatric Education Center External Consultant, 1992. United States Pharmacopeial Convention (USP) Gerontology Expert Committee, 2000-5. Commission on Certification in Geriatric Pharmacy, Exam Preparation and Review Committee, 2001-2003. State- 8 -
State Tripartite Committee on Internship (RI), 1972-76. Student Affairs Comm.Chair, RI Society of Hospital Pharmacists,1974-76. Georgia Society of Hospital Pharmacists (GSHP),Continuing Education Committee 1977-79, 1988-89; Professional Affairs Committee, 1990-91. Georgia Pharmaceutical Association, Academy of Consultant Pharmacists, 1978-1993; Committee on Services and Reimbursement ,1979-80; Board of Directors, 1978-80, 1987-88; Commission on Pharmaceutical Care, 1992-, Research and Education Foundation Consultant, 1992; Medicaid Long Term Care Study Committee, 1994-5. University- Curriculum Committee, Chairman, Sub-committee to Formulate Pharm.D.,URI,1972-75. Pharmacy and Therapeutics Committee, Potter Health Services, URI,1972-73. Drug Abuse and Public Relations Committee, URI, 1972-73. Clinical Pharmacy Advisory Committee, URI,1972-74. Building Committee, URI, 1972-74. Graduate Studies Committee, College of Pharmacy, URI, 1975-76. Affirmative Action Committee, URI, 1973. Joint Clerkship Planning Comm. URI-Brown University Medical School 1973-76. Chairman, Clinical Pharmacy Committee, URI, 1974-76. University Budget Comm., Sub-Committee on Clinical Services/Consultation, URI, 1975. Admissions Committee, URI Sigma XI Ch.1975-76. Externship/Clerkship Committee, UGA, 1976-1990. Chair, Self Study Committee on Clinical Pharmacy, UGA, 1977. Chair, Clinical Faculty Positions Selection Committee, UGa, 1977-80. Chair, Assistant Dean Search Committee for Medical College Program, UGa,1979-80; 1985-6. Chair, Curriculum Committee, UGa College of Pharmacy,1981-82. Chair, Doctor of Pharmacy Committee, College of Pharmacy, UGa,1980-85. Health and Clinical Sciences Committee on Promotion, UGA, 1983-86. University Faculty Grants Committee, UGa, 1985-87. Chair, Task Force for Doctor Pharmacy Conversion Consideration, UGa, 1988. Creative Research Awards Selection Committee, UGa,1986-88. Chair, Sub-Committee on Institutional Development, UGa 1990 Accreditation Self-Study Committee on Administrative Processes, UGa,1990. Chair, Clinical Resources Committee, College of Pharmacy Self-Study for Accreditation, 1989-91. Executive Committee, College of Pharmacy, UGa, 1978-94.
NCAA Self-Study for Certification of Athletic Programs, Sub-Committee for Rules and Governance, 1994-5. Promotion and Tenure Appeals Review Committee, UGa,1996-1998 Building and Facilities Committee, 1994-5 Gerontology Program- University System-Wide Consortium, Grant Review Committee, 1998- University Council Program Review Committee, 1999- Institutional- 9 -
Patient Records Systems Implementation Consultant NE Georgia Area, 1969-72. Educational Consultant, School of Nursing and Department of Medical Education, St. Joseph's Hospital, Providence, Rhode Island, 1972-76. Systems Consultant to Rhode Island Medical and Mental Health Centers, 1972-76. Project Coordinator, State of Rhode Island, for Institute of Clinical Toxicology Drug Abuse-Misuse Study, 1973-75. American Association of Nurse Anesthetists, 1972-76. Board of Regents, University System of Georgia Pharmacy Services, 1977. Gracewood State Mental Retardation Center, Augusta, GA, 1977-79. Georgia Retardation Center, Athens, 1978-80. St. Mary's Hospital Institutional Review Board, 1977-93. Athens Health Care Center (AHC), l976-91, and Banks-Jackson-Commerce Nursing Home Pharmaceutical Services Committees, l980-92. AHC Infection Control Committee,1976-91. Area-Oconee-Oglethorpe County Primary Health Care Centers Governing Board, 1979-81. College- Executive Committee, 1977-1994, Curriculum, 1978-1983 and 1998-, Promotion and Tenure, 1998-, Academic , 1999-2000, Admissions, 2000-2003 Department- Graduate Education, 1997-, Third Year Review Chair 1999. Industry- Shift Chemist, Chemical Division, Union-Bag Camp Paper Corporation, Savannah, Georgia (1964-5); Service on advisory boards and/or speaker panels, instruction and research support from pharmaceutical companies as noted under funding section. These companies have included (before mergers not guaranteed to be current titles) Abbott, AstraZeneca, Aventis, Bayer, Boehringer-Ingleheim, Bristol-Myers Squibb, Ciba-Geigy, Marion-Merrell-Dow, Merck, Janssen, Glaxo-SKB, Lederle, Pfizer-Roerig, Proctor and Gamble, Ortho-McNeil, Purdue-Pharma, Pfizer-Roerig, Lilly-Dista, Merck, Organon, Roxane, Forest , Watson Labs and Novartis. None are currently active. Editorial- Contributing Editor, International Pharmaceutical Abstracts,1972-76. Contributor, St. Joseph's Hospital P&T Newsletter,1973. Editor, Pharmacy Newsletter, Potter Health Services, URI, 1972. Reviewer, Journal of Pharmaceutical Sciences, 1974- Reviewer, American Journal of Pharmaceutical Education,1975-. Reviewer, Journal of the American Pharmaceutical Association, 1975-79. Reviewer, Drug Development Communications, 1975-78. Reviewer, USP Dispensing Information and Patient Advice, 1977-2002.
Contributing Editor, Georgia Pharmacist Quarterly, 1978-1985. Reviewer and Editorial Board, Contemporary Pharmacy Practice, 1978-83. Editorial Consulting Panel, Hospital Formulary, 1979-81. Contributing Editor, Contemporary Administrator, 1979-83. Reviewer, Journal of Gerontology, 1979-. Reviewer, American Journal of Hospital Pharmacy, 1979-. Editor, Clinical Consult (ASCP), 1982-1995. -10 -
Reviewer, Drug Intelligence and Clinical Pharmacy,(now Annals of Pharmacotherapy 1983-. Contributing Editor and Editorial Board, Nursing Homes, 1984-1994. Contributing Editor, "monitoring" Series U.S. Pharmacist, 1984-5. Reviewer, Medical Care, 1985-. Reviewer, American Journal of Medicine, 1987-. Editorial Board, Journal of Pharmacoepidemiology, 1988-1999. Reviewer, Hospital Pharmacy, 1985-. Reviewer, Geriatric Medicine Today, 1988-90. Regimen, Reviewer 1990-1994; author, 1994-2003. Editorial Board, Nursing Home Practitioner,1993-1996. Publisher, Cooper Consultant Press, 1993- at www.cooperconsultantpress.com. Reviewer, Southern Medical Journal, 1994-. Founding Editor, Journal of Geriatric Drug Therapy, 1984-1999. Reviewer, American Journal of Managed Care, 1998- Editorial Board, Annals of Long-Term Care, 1999- Reviewer, Pharmacotherapy, 1999- Reviewer, Journal of Research in Pharmaceutical Economics, 2000- Reviewer, Journal of the American Medical Directors Association, 2000- Reviewer, Journal of the American Geriatrics Society, 2000- Reviewer, Clinical Pharmacokinetics Handbook, ASHP, 2000- Reviewer, Pharmacotherapy Self Assessment Program, ACCP, 2000- Editorial Board, The Natural Pharmacist (tnp.com) 2000-2002 Reviewer, Social Science and Medicine, 2001- Clinical Editor, Nursing Homes and Senior Care, 1992-2003 Editorial Board, The American Journal of Geriatric Pharmacotherapy, 2003-12 Reviewer, The Lancet, 2006- Reviewer, The Journal of Applied Gerontology, 2008- Reviewer, Age, The Journal of the American Association for Aging, 2010- Reviewer, Archives of Gerontology and Geriatrics, 2011- Reviewer and Advisory Board, Geriatric Pharmacy Review Course, ASCP, 2011. Editorial Board, Journal of Gerontology and Geriatric Research, 2012- Editorial Review Board- The Consultant Pharmacist, 2013- Honors-Dean's List throughout Pharmacy School, University of Georgia, first in academic rank in class upon graduation,(92.6 average). National Science Foundation Traineeship (1969-1972), Lederle Faculty Award (1974). Co-author Roche Hospital Pharmacy Award
(1973). Selected for fellowship (FCP) in American College of Clinical Pharmacology (1976), American Society of Hospital Pharmacists (ASHP) Award for Practice of Hospital Pharmacy (1978). Elected Fellow, American College of Clinical Pharmacology (1979- inactive). Co-author, American Society of Consultant Pharmacists Research Paper Award (1980) (with Lawler and Kotzan). Archambault Award, American Society of Consultant Pharmacists (1982). Ad hoc advisor, White House conference on Aging (1981). Co-Author American Society of Consultant Pharmacists (ASCP) Research Papers Award (1983) (with -11 -
L. Pink). Nominated for Brookdale Award in Gerontology by ASCP and ASHP, 1980 and 1981. Fulbright Award to Zimbabwe 1984 (declined). ASCP 1st Place Paper Award, 1984; ASCP 2nd Place Paper Award, 1986. Creative Research Medal, University of Georgia (l985). McNeil Clinical Pharmacy Research Award, (1987). Fellow, American Society of Consultant Pharmacists, (1989-Lifetime). 1990 American Society of Hospital Pharmacists Research and Education Foundation Award for Sustained Contributions to the Literature of Hospital Pharmacy. Fellow, American Society of Hospital Pharmacists, (1992-). Presenter, First Peter P. Lamy Memorial Lecture, ASCP, 1999, Pinnacle Award, APhA and HCQA, 2000,Teacher of the Year, College of Pharmacy, 2001 and dedication of Georgia pharmacist Magazine for 2001, nominated for Russell Miller Award of ACCP, 2002 &2003. Appointed to CGP Credentialing and Exam Committee, 2002-2005. Honored with Member Profile in The Credential of CCGP Vol. 4, no. 4, 2001. Nominated for University Professorship, 2002. Named Albert W. Jowdy Professor of Pharmacy Care, 2002-2003. Emeritus AW Jowdy Professor, 2003-passing. Phi Delta Chi Teacher of the Year, 2006. ASCP Leadership in Education Award, 2009. Named lifetime Fellow ASCP, 2013. Scholarships:Undergraduate (1966-68)-American Foundation for Pharmaceutical Education, Pharmacy Alumni Society, Georgia Pharmaceutical Association and School of Pharmacy; Graduate - National Science Foundation Traineeship (1969-72). Current and Former Professional Memberships:c=current American Pharmaceutical Association American Society of Consultant Pharmacists, Fellow, c American Society of Hospital Pharmacists, Fellow American College of Clinical Pharmacy American Association of Colleges of Pharmacy American Geriatrics Society Georgia Pharmaceutical Association Georgia Society of Consultant Pharmacists, c American Medical Directors Association (affiliate member)
Honorary Societies Sigma Xi, Phi Kappa Phi, Rho Chi, Phi Lamda Sigma Fraternities Tau Kappa Epsilon, Phi Delta Chi Publications- Research (R-x) *=refereed 1. *Cooper JW. Serotonin and growth antagonists. New Engl J Med 1973; 289:870 (Letter). 2. *Cooper JW, Ansel HC, Cadwallader DE. Liquid and solid solution interactions of primary certified colorants with pharmaceutical gelatins. J Pharm Sci 1973;62:1156-1164. 3. *Cooper JW, Fish KH, Loomis M et al., A seven nursing home study of the frequency of potential drug-drug interactions. J Am Pharm Assoc 1975; NS23:24-27. -12 -
4. *Cooper JW, Frisk PA, Walchle RC. Continuous clinical pharmacy care-a method to reduce drug-related problems in the small community. J Clin Pharmacol 1975; 15: 55. 5. *Cooper JW, Rhodes CT, Birmingham BK. Pharmacokinetics of salicylic acid. Arch Derm 1976; 112:1610 (Letter). 6. *Lewis KP, Cooper JW, McKercher PL. Pharmacist effect on digoxin usage and toxicity. Amer J Hosp Pharm 1976;33:1272-1276. NOTE: Dr. Lewis was first recipient of the ASHP Student Research Award in 1978 for this work. 7. *Frisk PA, Cooper JW, Campbell NA. Community-hospital pharmacist detection of drug-related problems upon admission to small community hospitals. Am J Hosp Pharm 1977;34:738-742. Note: This work received the ASHP Award for Achievement in the Professional Practice of Hospital Pharmacy in 1978. 8. *Schwartz PA, Rhodes CT, Cooper JW. Solubility and ionization characteristics of phenytoin. J Pharm Sci 1977;66:994-997. 9. *Cooper JW, Bagwell CG. The contribution of the consultant pharmacist to rational drug usage in the long term care facility. J Am Geriatr Soc 1978;26:513-520. 10.*Cooper JW, Pesnell LS. Thioridazine-associated immune hemolytic anemia in an elderly female. Sou Med J 1978;71:1441-1442. 11.* Cooper JW, Walchle RC, McKercher PL. Physician, pharmacist and nurse-conducted drug histories. Contemp Pharm Pract 1980;3:75-78. 12.*Cooper JW, McCall CY. Tetracycline esophagitis-report of three cases. Pharm Practice. 1979;14:52. 13.* Cooper JW, McCall CY. Tolmetin anaphylactoid reaction. JAMA 1980;243:1263. 14.* Cooper JW. Consultant contributions to rational drug therapy in the long term care facility. Contemp Writings on Long Term Care Pharmacy 1980;2:161-168. 15. *Wade WE, Whaley JA, Cooper JW, Brown RH. Pharmacist involvement in Georgia public health department-preliminary report of two pilot studies. Ga Pharm J 1981;3:20-22. 16.*Wilcher DE, Cooper JW. Consultant pharmacist effect on analgesic and
antiinflammatory usage in geriatric long-term care facility. J Am Geriatr Soc 1981;29:429-432. NOTE: Ms. Wilcher was Sigma Xi Student Research Awardee for this work in 1982. -13 -
17. *Tsai AE, Cooper JW, McCall CY. Consultant pharmacist effect on hematopoietic and vitamin therapy in a geriatric long-term care facility. Hosp Form 1982;17:225-235. 18.* Lawler RS, Cooper JW, Kotzan JA. Consultant pharmacist input in the treatment of urinary tract infections in a geriatric long-term care facility. Hosp Pharm 1980;15:562-572. 19. *Cooper JW, Francisco GE. Consultant clinical pharmacist: effect on psychotropic drug usage in long-term care facility geriatric patients. Hosp Form 1981;16:407-419. 20.*Williamson DH, Cooper JW, Kotzan JA. Consultant pharmacist impact on antihypertensive therapy in a geriatric long-term care facility. Hosp Form 1984;19:123-128. 21. *Cooper JW. Baked chicken liver and blood pressure increases in geriatric nursing home patients. Am J Clin Nutr 1979;32:1980. 22.* Cooper JW et al., Pharmacy and the Elderly: An Assessment of the Needs of the Elderly and Recommendations for Increasing Geriatric Aspects of Pharmacy Curricula, DHEW Pub. No.(HRA) 80-37 (September, 1979). 23. *Cooper JW, Griffin DL, Francisco GE, et al. Home health care: drug-related problems detected by consultant pharmacist participation. Hosp Form 1985;20:643-650. 24.* Wiederholt J, Kotzan JA, Cooper JW. A tachistoscopic examination of auxiliary prescription labels. Drug Intell Clin Pharm 1983; 17:216-221. 25.*Spruill WJ, Cooper JW, Taylor WJR. Pharmacist-coordinated pneumonia and influenza vaccination program. Am J Hosp Pharm 1982; 39:1904-1906. 26.* Spruill WJ, Cooper JW. Enteric-coated aspirin efficacy in patients previously treated with non-steroidal antiinflammatory agents. Sou Med J 1983; 76:276. 27. *Cooper JW. Drug-related problems in geriatric LTCF patients. J Geriatr Drug Ther 1986; 1(1):47-68. 28.* Cooper JW. Effect of initiation, termination and reinitiation of consultant pharmacist services in a geriatric LTCF. Med Care 1985;23:84-86. 29.*Cooper JW, Morgan SM, McCall CY, et al. Dexamethasone prevention of cisplatinum-induced nausea and emesis. Curr Ther Res 1985; 38:43-49. 30.* Cooper JW, Cobb HH, Shepherd MD. Drug discards in two Georgia long-term care facilities. Ga Pharm J 1985; 7:11-15. -14 -
31.* Cooper JW, Stegeman JF. Sulfisoxazole-induced hypoprothrombinemia in an elderly female. J Med Assoc Ga 1981; 70:875-877. 32.* Pink LA, Cooper JW, Francis WR. Digoxin-related communications in a long term care facility. Nurs Homes 1985; 34(1):25-31.
33.* Durrence CE, Cooper JW. Gastrointestinal side effects associated with liquid and solid dosage forms of potassium chloride. Curr Ther Res 1984;36:550-556. 34.*Cooper JW. Efficacy and cost-effectiveness of a new diuretic-combination antihypertensive in a geriatrics long term care facility. Curr Ther Res 1986; 39:160-165. 35.* Wade WE, Cobb HH, Cooper JW. Drug-related problems in a geriatric ambulatory population. J Geriatr Drug Ther 1986; 1(2):101-110. 36.* Durrence CE, May JR, DiPiro JT, Cooper JW. Potential drug interactions in surgical patients. Am J Hosp Pharm 1985; 42:1553-1556. 37. Cooper JW. Trans-dermal nitroglycerin efficacy in ambulatory and nursing home geriatric patients. MCP CE Bulletin 1986; 6:25-32. 38. Cooper JW. Drug-related problems in nursing home patients. Nurs Homes 1986;35(6): 13-19. 39. Cooper JW. Communications on drug-related problems within nursing homes. Nurs Homes 1987; 36(1):11-14. 40.Cooper JW. Drug-related problems in nursing homes: Medication Errors.Nurs Homes1987; 36(2):13-16. 41. Cooper JW. Drug-related problems in nursing home patients: contraindications to drug usage. Nurs Homes 1987;36(3):5-7. 42. Cooper JW. Adverse drug reactions and interactions in a nursing home. Nurs Homes 1987; 36(4):7-11. 43.Cooper JW. Nutritional problems in nursing home patients. Nurs Homes 1987; 36(5):5-8. 44. Cooper JW. Nursing home drug and nutritional therapy cost-savings by the consultant pharmacist. Nurs Homes 1987; 36(6):6-8. 45. Cooper JW. Reduction of irrational drug duplication in geriatric nursing homes. Nurs Homes 1988; 37(1):5-9. -15 -
46. Cooper JW. Lack of efficacy of nursing home medications. Nurs Homes 1988;37:(2)6-10. 47. Cooper JW. Underecognition and undertreatment of geriatric nursing home patients. Nurs Homes 1988;37(3):6,9. and *Ga J Hosp Pharm 1989;2(2):18-20. 48. Cooper JW. Lab tests under-and overutilization in geriatric nursing home patients. Nurs Homes 1988;37(4):5-8. 49. Cooper JW. Inappropriate drug scheduling. Nurs Homes 1988; 37(5):13-15. 50.* Cooper JW, Cobb HH. Patient nutritional correlates and changes in a geriatric nursing home. Nutr Supp Serv 1988; 8(8):5-7. 51. *Wade WE, Cooper JW. Iatrogenic hyperkalemia in a elderly female. J Geriatr Drug Ther 1986; 1(1):75-79. 52.* Cooper JW, Wade WE, Mallet L. Anemia detection and treatment in a four geriatric long term care facility population. J Pharmacoepidem 1990; 1(1):61-70.
53. *Cooper JW. Nursing home admission orders and the consultant pharmacist. Cons Pharm 1987; 2:152-156. 54.* Cooper JW, Doyal LE. Cost-justification of the clinical pharmacist in a community mental health center. Med Interface 1989; 2(11):44-48. 55.* Cooper JW. Drug-related problems in geriatric day care patients. Cons Pharm 1988;3(2):193. 56.* Cooper JW. Reduced eye infections in geriatric patients by consultant pharmacist recommendation of continual use of artificial tears. Cons Pharm 1988;3(3):83. 57.* Cooper JW. Drug-related problems (DRPs) in geriatric swing bed patients.Cons Pharm 1988;3 (3):83. 58.* Cooper JW. Cost-savings from discontinuance of urinary sugar and acetone tests. Cons Pharm 1988;3(3):83. 59.* Morton MR, Spruill WJ, Cooper JW. Pharmacist impact on pneumococcal vaccination rates in LTCFs. Am J Hosp Pharm 1988; 45:73. 60.* Cooper JW. Chronic constipation associations and laxative efficacy in a geriatric nursing home population. J Pharmacoepidem 1991;1(3/4):29-40. -16 -
61.* Mallet L, Cooper JW. Catapres TTS medication error. Sou Med J 1988; 81:1597-1598. 62.* Cooper JW, Mallet L. Chlorpropamide half-life and urine pH. Am J Med 1988; 85:756-757. 63.* Mallet L, Cooper JW, Thomas J. Captopril pemphigoid reaction. Drug Intell Clin Pharm.1989; 23:63. 64.* Fazio A, Lisi DM, Cooper JW. Acetazolamide Acidosis. J Geriatr Drug Ther 1989;3(3):87-96. 65.* Mallet L, Coulter J, Cooper JW. Cholesterol levels in elderly patients living in a nursing home .Cons Pharm 1989;4:371-373. 66.* Morton MR, Cooper JW. Erythromycin-induced digoxin toxicity. DICP-Ann Pharmacother 1989; 23:688-9. 67. Cooper JW. Psychoactive drug use and misuse in a 200-bed nursing home population. Nurs Homes 1989;38(1-2):5-7. 68.* Cooper JW, Gordon JE, Parish RC. Diabetes mellitus prevalence and treatment outcomes in a geriatric nursing home population. J Geriatr Drug Ther. 1990; 5(1):73-82. 69.* Cooper JW. Renal function assessment in nursing home patients. A prospective 6-month study in 282 patients. J Geriatr Drug Ther 1991; 5(3):59-72. 70. *Cooper JW. Drug assessment in nursing home patients with renal impairment.J Geriatr Drug Ther 1991; 5(1):73-88.and J Pharmacoepidem. 1992;2(4):3-12. 71.* Mallet L, Cooper JW. Prolongation of prothrombin time with the use of piroxicam and warfarin. Can J Hosp Pharm 1991;44(2):93-4. 72. Cooper JW. Managing depression and depressive symptoms:a five-year study. Nurs Homes 1993; 42(2):37-39. 73. Cooper JW. ACEI Drug Interactions (case reports). Nurs Home Pract 1994;2(5):28-30.
74.* Cooper JW. Falls and fractures in nursing home patients receiving psychotropic drugs.Internat J Geriatr Psych 1994;9:975-80. 75.* Cooper JW. Pharmacotherapy Recommendations from Monthly Drug Regimen Reviews in a Geriatric Nursing Facility: A One-Year Study. Pharmacotherapy 1994; 13:687 -17 -
76.* Cooper JW. Consultant pharmacist contribution to diabetes mellitus treatment outcomes in two patient outcomes in two nursing facilities. Cons Pharm 1995;10(1):13-18. 77.* Cooper JW. Adverse drug reactions and interactions in a geriatric nursing home population over 4 years. J Am Geriatr Soc 1996; 44:194-197. 78.* Cooper JW. Falls in nursing home patients receiving classical antihistamines while stabilized on psychoactive medications, J Pharmacoepidem 1996; 5(1):45-50. 79.* Cooper JW. Health Care Costs and Outcomes from Consultant Pharmacist Recommendations in A Geriatric Nursing Facility: A One-year Study. J Geriatr Drug Ther 1997: 11(4):51-73.; also published as Cost-benefit analysis of consultant pharmacist recommendations from monthly drug regimen reviews in a geriatric nursing facility; a oneyear study in J Pharmacoepidem 1997: 6(1): 23-36. 80.* Cooper JW. Geriatric drug therapy interventions. J Geriatr Drug Ther 1997; 11(4):3- 26. 81.* Cooper JW. Geriatric drug therapy intervention failure and associated costs. J Geriatri Drug Ther 1997;11(4):65-70. 82.* Wade WE, Cooper JW. Bowel obstruction associated with fiber administration within an entire nursing facility population, J Geriatr Drug Ther 1997; 12 (1):94-94. 83.* Cooper JW, Wade WE. Repeated unnecessary NSAID-associated hospitalizations: a case report. J Geriatr Drug Ther 1997; 12 (1): 95-98. 84.* Wade WE, Cooper JW. Severe tardive dyskinesia and weight loss associated with metoclpropamide administration with haloperidol: a case report. J Geriatr Drug Ther 1997; 12 (1): 99-104. 85.* Cooper JW, Wade WE. Possible lower bowel perforation associated with ibuprofen administration: a case report. J Geriatr Drug Ther 1997; 12 (1): 105-108. 86.* Cooper JW. Consultant pharmacist effect on NSAID costs and gastropathy over a 5- year period. Consult Pharm 1997; 12:792-796. 87.* Cooper JW. Consultant pharmacist assessment and reduction of fall risk in nursing facilities. Consult Pharm 1997; 12: 1294-1304. 88.* Cooper JW. Consultant pharmacist assessment of fall injury incidence and costs within a nursing facility. Consult Pharm 1997; 12: 1305-1309. -18 -
89.* Cooper JW. Reducing falls among patients in nursing homes. JAMA 1997;278: 1742.
90.* Cooper JW. Consultant pharmacist drug therapy recommendations from monthly drug regimen reviews in a geriatric nursing facility: a two-year study and cost analysis. J Nutri Health and Aging 1997; 1(3): 181-184. 91.* McRae A, Cooper JW. Use of nonaggressive short-term nutritional supplementation in a skilled nursing facility. Consult Pharm 1998; 13:174-181. 92.* Beach JW, Cooper JW, Francisco GE, Langford A. An infectious disease course for an entry-level doctor of pharmacy program. Am J Pharm Ed 1998; 62(2): 296-301. 93.* Cooper JW. Fatal asymptomatic hypoglycemia in an elderly insulin-using diabetic patient, Diabetes Care 1998; 21(12):9-10. 94.* Cooper JW. Oral agent treatment of type 2 diabetes mellitus in older adults. Ann Long Term Care-Nursing Home Medicine 1998; 6: 414-422. 95.* Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. Sou Med J 1999; 92:485-490. 96.* Cooper JW. Psychoactive drugs may have a role in pressure sore origin. Br Med J 2000; 321:452. 97.* Cooper JW, Cobb HH, Burfield AH. A one year study of psychotropic load reduction and buspirone conversion possible effects on behavioral disturbances and global deterioration in a rural nursing home population, Cons Pharm 2001; 16(4):358-363. 98. *Cooper JW, Horner MR. Psychotropic load and falls in nursing facility residents, in review. SE Post-Graduate Symposium Fall 2000(nominated for ASHP Student Research Award for 2000) 99.* Cooper JW. Drugs may have reduced effect of falls intervention. Br Med J 2001; 322:675. 100.* Cooper JW. Reducing psychotropic drugs reduces falls in elderly people. Br Med J 2001; 323:402. 101.* Fick DM, Cooper JW, Wade WE, Waller J, McLean R, Beers MH. Updating the Beer’s criteria for Potentially Inappropriate Medication Use in Older Adults. Archives of Internal Medicine, 2003;163:2716-2724. 102. Cooper JW, Burfield AH. Anticholinergics to Avoid with Cholinesterase Inhibitors. Ann Long Term Care 2003; 4(11): 50-51. -19 -
103.* Cooper JW, Burfield AH. Response to Anticholinergics to Avoid- Quarternary vs. Tertiary Ammonium Antimuscarinics, ibid, May, 2003. 104.* Cooper JW. Pseudoephedrine adverse drug effects, Drug Topics 2004; 23;56. 105. *Cooper JW., Wade WE. Pharmacists interventions in geriatric nursing facility-NSAID Therapy . Cons Pharm 2005; 20(6): 492-7. 106. *Perri M, Menon AM, Desspande AD, Shinde SB, Jiang R, Cooper JW et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother
2005; 39; 405-11. 107.* Cooper JW, Burfield AH. Management of the cognitively impaired residents: a practical guide for long-term care. ElderCare 2005; 5(1):3-5. 108.* Cooper JW, McCall CY, Marshburn RP, Burfield AH. A senior care clerkship for pharmacy students. Consult Pharm 2006;21:482-92. 109.* Cooper JW, Burfield AH. Transitional care of elderly residents with anemia. ElderCare 2005; 6(2):1-5. 110.* Cooper JW, Freeman MH, Cook CL, Burfield AH. Psychotropic and Psychoactive Drug Load Assessment and Falls in Nursing Facility Residents.Consult Pharm 2007:22:483-9. 111.* Cooper JW, Freeman MH, Cook CL, Burfield AH. Psychotropic and Psychoactive Drugs and Hospitalization Rates in Nursing Facility Residents. Pharmacy Practice 2007;5(3):140-4. 112.* Cooper JW, Wade WE, Cook CL, Burfield AH. Consultant Pharmacist Drug Therapy Recommendations Acceptance and Rejection from Monthly Drug Regimen Reviews in A Geriatric Nursing Facility: Fourth Year Results and Cost Analysis. Hosp Pharm 2007;42:729-36. 113. *Cooper JW, Burfield AH. Medication Interventions for Fall Prevention. Geriatrics and Aging, 2009 ;12(10): 518-23. 114. Cooper JW, Burfield AH. Medications and Fall Risk Reduction by the Pharmacist. Pharmacy Today May 2009 and J APhA, 2009:49:70-84. 115. Cooper JW, Burfield AH. Assessment and management of chronic pain in the older adult. Pharmacy Today, May 2010 and JAPhA, 2010:50;89-101. -20 -
116. Burfield AH, Won TTH, Sole ML, Cooper JW. Behavioral cues to expand a pain model of the cognitively impaired elderly in long-term care. Clin Interv Aging 2012: 117. Burfield AH, Won TTH, Sole ML, Cooper JW, A study of longitudinal data examining concomitance of pain and cognition. J Pain Research 2012: 5; 1-10. in an elderly long-term care population. 118. Burfield AH, Cooper JW. Examining the case for involuntary weight loss after switching acetylcholinesterase inhibitors. Annals of Long-Term Care: Clinical Care and Aging. 2013;21(3):35-37 119. Cooper JW. Ask The Expert: Safe Use of Anticonvulsants in Older Patients with Epilepsy. Annals of Long-Term Care: Clinical Care and Aging. 2013;21(7):42-46 and July 2013 issue of Clinical Geriatrics. 120. Burfield AH, Cooper JW. Teaching Students to Teach About Safe Medications. The Consultant Pharmacist 2013 (May); 28 (5):267. .
Professional Articles (JWC single author unless otherwise noted) ( P-x) Refereed=* 1. The emphasis is on clinical pharmacy. Pharm Quart 1974;6:5-8. 2. *Hexachloraphene vs. povidone-iodine in the control and prophylaxis of neonatal and surgical infection. Hosp Form Mgt 1974; 9:12-14. 3.* Cooper JW, Campbell NA. Community-hospital practitioner consultation: is the patient profile a viable means of future role expansion and professional unification. J Amer Pharm
Assoc 1975; NS15 484-488. 4.* Fish KH, Cooper JW. The development of a non-computerized system for drug-drug interaction detection. J Amer Pharm Assoc 1975;NSl5:1,28-31. And 2000; 40:545. 5. The Common Cold and Cold Remedies, syndicated to 200 New England Newspapers via University of Rhode Island Public Information Office, January 1975. 6. Upper and Downers, syndicated to 200 New England Newspapers via University of Rhode Island Public Information Office, February, 1975. 7.* Fish KH, Cooper JW, Schwartz PA. Teaching process skills in clinical pharmacy orientation. Am J Pharm Ed 1975;40:306-309. 8.* Implications of Drug Reactions--Recognition, Incidence and Prevention, RI Med J 1975; 59:274-288. -21 -
9. Patient Profiles--Why Bother?.Pharm Quart 1975; 7: 3-7. 10. Community and Hospital Pharmacist--How They Cooperate to Reduce Medication Problems. Pharm Times 1975;41; 40-44. 11. Pharmacists Work Together to Improve Patient Care.Trends in Pharmacy (July-August, 1975). 12.* Food-Drug Interactions. US Pharm 1976; 1:17-28. 13.* Drug-Related Problems and the Elderly. Sou Pharm J 1977; 69:11-15. 14.* Urinary Tract Infections I.Cause and Prevention. Hosp Form 1977;12:106-110. 15.* Urinary Tract Infections II.Optimal Therapy. Hosp Form 1977; 12:175-183. 16.* Creatinine Clearance Projection. Hosp Form 1977; 12:283. 17.* Chronic Obstructive Airway Disorders I. Asthma. Hosp Form 1977; 12:524-529. 18.* Chronic Obstructive Airway Disorders II. Chronic Bronchitis and Emphysema Hosp Form 1977;12:579-582. 19.* Cooper JW, et al.Patient Medication Profiles. Pharm J of Great Britain 1977; 52-71. 20. *Nalidixic Acid. Hosp Form 1977; 12:634-6 (Letter). 21.* Drug Therapy in the Elderly-Is It All It Could Be? Amer Pharm 1978;NS18:25-26. 22.* Prophylaxis with Steroids in Asthma. Hosp Form 1978;13:654-656 (Letters). 23. Drug-Related Problems and Patient Education.Ga Pharm Quart 1978; 55:1. 24.* Cooper JW, et. al. Pharmacy and the Elderly, U.S. DHWE HRA- Pub. No. 232-78-0176 (February 15, 1979). 25.* The Role of Clinical Pharmacy in Pharmacy Practice.Ga Pharm 1979; 32:8-9. 26. Standards for Consultant Pharmacy. Contemp Adm 1979; 2:18-19. 27. Drug Use Review in LTCF. Pharm Pract editorial, 1979; 12:30. 28. Drug Distribution Systems in LTCF. Contemp Adm 1979; 2:21-22. -22 -
29. Clinical Functions of the Consultant Pharmacist,ibid.(7), 1979; 19-20, 30. 30. Literature of Consultant Pharmacy, ibid.(8):26-7. 31. Medication Errors in the LTCF-Definition, Recognition and Prevention,ibid.(10), 27-28. 32. Drug History-Acquisition, Interview, Evaluation and Communication, ibid.,3:18-19 (January, 1980). 33.* Diuretics in the Elderly Patient. Drug Ther 1979; 9:l0 (Letter).
34. Committee Functions of the Consultant Pharmacist. Contemp Adm 1980;3(2):17-18. 35. Drug-Related Problems and the Geriatric Patient. Drug Store News 1980;3(4):8-16. 36. Writing A Problem List for the LTCF Patient, Contemp Adm 1981; 3(4):6-8. 37. Stop Order Policy for the LTC Facility. Contemp Adm 1980; 3(5):12. 38. Policy and Procedure Manual Development, ibid., 1981; 4(1):9. 39. Professional Publications. Ga Pharm Quart 1980; 57, (4):2. 40. Drug Regimen Review in the LTC Facility. Contemp Adm 1980; 3(7):98. 41. Formulary System in Long Term Care Facilities,ibid., 1981; 4(3):11. 42. Consultant Pharmacy Roles and Resources. Drug Store News 1981;3:2. 43. Books for Continued Clinical Education. Ga Pharm Quart 1981;58 No. 1, 2. 44. Practitioner-Oriented Periodicals. Ga Pharm J 1981; 4:1. 45. Pharmacist Clinical Functions I-Drug History.Drug Store News 1981;3 46. Vitamin K Deficiency and Replacement. Ga Pharm Quart 1981 58, (2):2. 47.* Assessing Antihypertensive Therapy in the Geriatric Patient. Clinical Cons 1981; l(4). 48. Adverse Drug Reactions and Interactions in the Long Term Care Patient. Contemp Adm 1981;4(9):30, 36. 49. Medication Regimen Compliance in the LTC Patient ibid. 1981; 4(10):20. -23 -
50. High Blood Pressure in the Elderly.ibid. 1981; 4(11):8,25.. 51. Diuretic Antihypertensives in the LTC Patient.ibid.1981; 4(10):20. 52. Potassium Supplementation in the LTC Patient.ibid. 1981; 4(12):40-41. 53. Sympatholytic Antihypertensives.ibid.1982;(1):30-31 54. Vasodilator Antihypertensives. ibid.1982; 5(2):18. 55. The Drug Cutbacks. Contemp Adm 1982; 5(3):32-33 56. Staff Education and Drug Use Control. Contemp Adm 1982; 5(5):8-10. 57. Nitroglycerin Oral Dosage Forms.ibid. 1982; 5(6):10-12. 58. Nitroglycerin Topical Dosage Forms. ibid. 1982; 5(7):7. 59. Beta Blocking Agents. ibid. 1982; 5(9):14. 60. The Problem List. Contemp Adm 1982; 5(12):26-28. 61. Consulting Pharmacist.ibid. 1983; 6(1):24. 62. Using the New Indicators.ibid. 1983; 6(2):4-6. 63. Drug Therapy Situations Requiring Communications.ibid. 1983; 6(3):18. 64. Drug Irregularities Documentation. ibid. 1983; 6(4): 4, 30. 65. Monitoring Drug Interactions in the Geriatric LTC Patient. Clin Consult,1983; 3: No. 2. 66. Use Digitalis with Care. Contemp Adm 1982; 5(11):34. 67. *Reactions to Post-Graduate Education. Drug Intel Clin Pharm 1984; 18:330. 68. *Allopurinol-Warfarin Interaction. Drug Ther 1984; 14:155. (letter) 69. Detection and Treatment of Sexually-Transmitted Diseases. Drug Store News 1985. 70. Nutrient and Drug Interrelationships ibid. 4 Apr 1985. 71. Digoxin Drug Interactions. Contemp Adm 1984; 7(2):20-22. -24 -
72. Diuretic Drug Interactions. ibid. 1984; 7(3):36-38. 73. Anticonvulsant Interactions ibid. 1984;7(4):19-23. 74. Consultant Pharmacist Qualifications and Functions. Nurs Homes 1984;33(2):12-13. 75. The Need for Consultant Pharmacist Services in Long Term Care ibid.33(6):11-12.
76. Medication Errors in Nursing Homes-Part I ibid. 1985;34(1):12-13. 77. Medication Errors in Nursing Homes Part II ibid. 1985(2);34:12-14. 78.* Sublingual Nitroglycerin at the Bedside. J Am Med Assoc 1984; 252:1926. 79. Antihypertensive Drug Interactions: Part I. Nurs Homes 1985; 34(3):11-12. 80. ibid. Parts II & III. 11-13. 81. Anticoagulant Drug Interactions. Part I. ibid.34(4):17-19. 82. ibid. Part II. 15-17. 83. Neuroactive Drug Interactions in the LTCF Patient: Part I- Assumptions and Questions. Nurs Homes 35:12-15 1986. 84. ibid. Part II 16-20. 85. Digitalis Drug Interactions. ibid. 1986;35 35-39. 86. Gastrointestinal Drug Interactions. ibid. 48-51. 87. Antidiabetes Drug Interactions. Ibid., 63-68. 88.* Wade WE, Cooper JW. Monitoring Therapy in the HypertensivePatient-I. US Pharm 1985; 10(6):46-53. 89. *Wade WE, Cooper JW. Monitoring the Hypertensive Patient II. Patient Information. ibid.(7):46-50. 90. Monitoring Anticonvulsant Drug Interactions and Blood Levels. Nursing Homes 1986; 35(6):11-13. 91. Monitoring Pulmonary Therapy ibid. 35(6):21-24. -25 -
92.* H-1 Blockers: Classical Antihistamines. New Engl Reg Allerg Proc 1987; 7:356-361. 93-103. Editorials. J Geriatr Drug Ther 1986-1988; 1(1):1.-2:(4):1 104.* Drug-Related Problems at all levels of Geriatric Patient Care. J Geriatr Drug Ther 1990; 4(3):79-83. 105.* Drug-Related Problems in Nursing Home Patients. Generat 1988; 12(4):56-7. 106.* Cost-Savings: The Value of the Pharmacist Consultant. J Pharm Pract 1988;1:173-7. 107.* Consultant Pharmacist Impact on Health Care in America. Cons Pharm 1988; 3:342-6. 108-116. Editorials. J Geriatr Drug Ther 1988-90 Vol. 3 No. 1 thru Vol. 4 No.4. 117. Current Geriatric Drug Therapy Literature Citations. J Geriatr Drug Ther 1987; 2(1):79-87. 118. Current Geriatric Pharmacokinetic Literature Citations ibid., 3(1):93-9. 119. Current Geriatric Cardiovascular Literature Citations. ibid. (2):105-113. 120. Current NSAID Literature ibid. (4):151-2. 121. Current Adverse Drug Reactions ibid. (3):107-9. 122. Current Immunotherapy, Psychotropic and Renal Function Literature ibid.4(3).77-79. 123. Physician and Pharmacist Roles in Patient Compliance. Pharm Times 1990;25:9-71. 124.* The Development of Geriatric Education in the United States of America,3rd International Congress on Geriatric Pharmacotherapy Proceedings, Alicante, Spain
October 1989 Geriatrica 1989;5(9):22-28, Pharmalink 1990; 3(6):9-21. and J Geriatr Drug Ther 1991; 5(4):21-38. 125. Mammy Blue. J Geriatr Drug Ther 1990; 4(3); 3-5. 126. Problems in Dealing With the Nursing Home Patient, ibid. 1990; 4(1):51-58. 127. *Special Drug Considerations in the Last Year of Life. Geriatr 1989;44(12):79-86. 128. Gramps. J Geriatr Drug Ther 1990; 4(4):5-6. -26 -
129.* Drug Abuse in Nursing Homes, used by Rep. Mario Biaggi as reference in Hearing before Select Committee on Aging, House of Representatives, 96th Congress, June 25, 1978. 130.* Management of Diabetes Mellitus Complications, Clinical Consult 1990; 9(3):1-6.131. Diabetes in the Elderly. J Geriatr Drug Ther 1990; 5(1):1-2. 132. Diabetes Citations. ibid. 85-87. 133. OBRA Regulations and Chemical Restraints. Nurs Homes 1990; 39(6):10-13. 134. Chemical Substance Impaired Health Care Professional ibid. (5); 6-7, 36. 135. Use of Chemical Restraints in Nursing Homes ibid.1989; 38 (1&2):5-7. 136. High Blood Pressure Monitoring Guidelines: Diuretics. ibid. (3):7-9. 137. Congestive Heart Failure Management Guidelines.ibid. 1990; 39(1):8-10. 138. High Blood Pressure Monitoring Guidelines: Sympatholytics and Vasodilators ibid. (2):7-9. 139-142. Editorials J Geriatr Drug Ther 1990-1991; 5(1-4). 143. *Geriatric Pharmacy Education in the United States of American ibid.; 5(4):26-38. 144. Renal Geriatric Citations, ibid. 5(3):91-3. 145.*Stroke Management. Clin Consult 1991;10(2):1-6. 146. *Peripheral Vascular Disease ibid. (3):1-6. 147. *Liver Assessment in Long Term Care Patients. ibid.(4):1-6. 148. What to Expect from your Consultant Pharmacist. Nurs Homes 1991; 40(1):37-39. 149. Pressure Sores in the Nursing Facility,ibid.(2):39-41. 150. Infection Control in Nursing Homes,ibid.(3):42-44. 151. Urinary Incontinence: An Underrecognized Problem, Nursing Homes, 1991; 40(4):46-48. -27 -
152. Diabetes Mellitus Management in the Nursing Home. Nursing Homes and Senior Citizen Care (NHSCC)1992; 41(1): 34-35. 153. Pain Management in Long Term Care. NHSCC 1992; 41(2): 26-28. 154. *Managing Antihypertensive Therapy in Long Term Care. Clin Cons 1992; 11(1): 1-8. 155. *Drug-related Problems in Geriatric Nursing Home Patients. Pharm Times 1992; 58(8):60-69. 156-7.* Drug-level Monitoring: Parts 1 and 2. LTC Pharmacist.1992;1(11). 3-5 and 1993; 2(1):2-3. 158. Managing Disruptive Behavioral Symptoms: Do's and Don't's.Nursing Homes 1993;42(1):35-37 and 1994;43(1):54-56.
159.* Effects of Dementia: Differentiating Dementing Illness and Related Problems. Amer Drug 1993; 29(Apr):59-68. 160. Drugs That Cause Falls in the Nursing Home. Nursing Homes 1993; 42(4):45-47. 161.* Clinical Outcomes Research in Pharmacy Practice. Amer Phar 1993;NS33(12):S7- S13. 162. Functioning in the "Real World" of Nursing Home Pharmacotherapy. NH Practitioner 1993;1(1):43-44. 163. *Peripheral Vascular Disease Basic Bibliography. Hosp Pharm 1994; 29(1):81-82. 164. *Management of Angina Pectoris. Clin Consult 1993; 12(8): 1-8. 165. *Management of Laboratory Tests I: Serum Chemistry, Renal Function and Urinalysis. Clin Consult 1994; 13 (1):1-7. 166. *Management of Laboratory Tests II: Hematology and Clotting. Clin Consult 1994; 13(2): 1-8. 167. *Stewart RB, Cooper JW .Polypharmacy and Aging. Drugs and Aging 1994;4(6):449- 461. 168. *Drug Therapy Problems in the Elderly. Generations 1994;18(2):19-27. 169. *Geriatric Pharmacotherapy Issues in the United States of America. J Geriatr Drug Ther 1996;11(4): 1-28. -28 -
170. Scheduled Drug in the Nursing Home. NH Practitioner, 1994;2(1):41-43. 171. *NSAIDs: Proceed with Caution.NH Practitioner 1994; 2(2):32-33. 172. Dementia,Depression and Drugs.Nurs Homes 1994; 43(2): 44-45. 173. Tuberculosis I: Assessing Risk and need for Treatment. Regimen 1994;3(4):1-5. 174. Tuberculosis II. Drug Treatment. Regimen 1994;3(5): 1-6. 175. *Medication Errors in the Elderly. Fl J Hosp Pharm 1994; 14(1):23-25. 176. Improving Professional Collaboration in Today's Nursing Home. Nurs Homes 1994; 43(5):32-38. 177. Keeping Scheduled Drugs Secure in the Nursing Home. Nurs Homes 1994:43(6):24- 25. 178. New Drug Developments. Nurs Home Pract 1994;2(3):33.35. 179. Pharmacotherapy:The OBRA Team-Physicians and Pharmacists Upgrading Therapy. ibid.2(4):31-34. 180. NSAIDs and the Elderly Patient. Regimen 1994;3(6):1-5. 181. Assessing the Need for Enteral Feedings.Regimen 1994;3(7):1-5. 182. Managing Acute and Chronic Pain. Regimen 1994;3(8):1-5. 183. Flu and the Elderly Patient. Regimen 1994;3(9):1-5. 184. Seizures and Related Medications in the Nursing Home Patient. Regimen 1994;3(10):105. 185. Managing Diabetes Mellitus in the Nursing Home Resident. Regimen 1994;3(11):1-5. 186. Stroke Management in the Nursing Home Resident. Regimen 1994;3(12):1-5.
187.* A Primer on Drug Level Monitoring of Nursing Facility Residents. Brown U LTC Quality Letter 1993;5(13):1-3. 188. *Careful Drug-Level Monitoring Reduces Drug Toxicity. ibid.5(14):1,6. -29 -
189-201. Editorials. J Geriatr Drug Ther 1991-1995; volumes 6-9 (1-4 each). 202. A Farewell. J Geriatr Drug Ther 1994;9(2):1. 203. Preventing Falls and Fractures. NH Pract 1994;2(6):28-30. 204. Anxiolytic Update NH Pract 1995;3(1):19-21. 205. Monitoring Pulmonary Therapy. Regimen 1995;4(1):1-4. 206. Preventing Falls and Fractures in Nursing Home Patients. Regimen 1995;4(2):1-4. 207. Monitoring Psychoactive Drug Use in Nursing Home Patients. Regimen 1995;4(3):1-4. 208. NSAIDs:Gastrointestinal Effects. Long Term Care Pharmacist 1994;3(7):3. 209. GI Disease Overview. GPhA Academy of Independent Pharmacists Newsletter 1995 (4 parts). 210. Antidepressant Need and Assessment and Usage. NH Pract 1995; 3(2):19-21. 211. Antidiabetic Usage in Long Term Care. NH Pract 1995; 3(3):27-30. 212. ACE Inhibitors and the Nursing Home Patient. Regimen 1995;4(4):1-4. 213. Understanding and Managing Sleep Disorders in the Nursing Home Patient. Regimen 1995;4(5):1-4. 214. Monitoring Parkinsonism Drug Therapy. Regimen 1995;4(6):1-4. 215. Antianginal Drug Therapy Management. Regimen 1995;4(7):1-4. 216. Assesing High Blood Pressure. Regimen 1995;4(8):1-4. 217. High Blood Pressure Medications: Diuretics & ACE Inhibitors. Regimen 1995;4(9):1-4. 218. Influenza and the Nursing Home Resident. Regimen 1995;4(10):1-4. 219. Blood Pressure Management in the Edlerly. Regimen 1995;4(11):1-4. 220. Use of Drug Levels I: Digoxin. NH Pract 1995;3(4):20-22. 221. Use of Drug Levels II: Theophylline and Anticonvulsants. NH Pract 1995;3(5):19-21. -30 -
222. Helicobacter pylori in Nursing Home Residents. NH Pract 1995;3(6):17-19. 223. Monitoring upper respiratory tract infections in the nursing facility resident. Regimen 1995; 3(12):1-4. 224. Monitoring lower respiratory tract infections in the nursing facility resident. Regimen 1996; 4(1):1-4. 225. Managing pneumonia in the nursing home. Regimen 1996; 4(2):1-4. 226. Managing acute UTIs in the nursing facility. Regimen 1996; 4(3): 1-4. 227. Managing chronic UTIs in the nursing facility patient. Regimen 1996; 4(4):1-4. 228. Skin Problems in the nursing facility:skin changes and atopic dermatitis. Regimen 1996;4(5):1-4. 229. Contact dermatitis, infections and infestations in the nursing facility. Regimen 1996;
4(6):1-4. 230. Prevention of pressure ulcers. Regimen 1996;4(7):1-4. 231. Treatment of pressure ulcers. Regimen 1996;4(8):1-4. 232. Precose for diabetes mellitus. Regimen 1996;4(9):1-4. 233. Glucophage for diabetes mellitus. Regimen 1996;4(10):1-4. 234. Fall risk assessment and reduction. Regimen 1996;4(11):1-4. 235. Osteporosis risk assessment and treatment. Regimen 1996;4(12):1-4. 236.* Cooper JW, Wade WE. Constipation in the Geriatric Patient, J Geriatr Drug Ther 1997:12(1): 49-70.. 237.* Cooper JW, Wade WE. Diarrhea in the Geriatric Patient ibid.: 71-92. 238. * Wade WE, Cooper JW. Gastroesophageal reflux disease in the elderly, ibid.:3-14. 239.* Wade WE, Cooper JW. Inflammatory bowel disease in the elderly patient, ibid.:33- 48. 240.* Antiinfective therapy in the geriatric patient. Infusion 1997;3(6):10-19. -31 -
241. Lung problems in the nursing home patient: acute and chronic cough, Regimen 1997;5(1):1-5. 242. COPD management considerations in the nursing facility. Regimen 1997;5(2):1-4. 243. Gastrointestinal problems in the nursing facility resident: nausea, vomiting, flatulence and lactase deficiency, Regimen 1997;5(3):1-5. 244. Hiatal hernia and gastroesophageal reflux disease in nursing facility residents. Regimen 1997;5(4):1-4. 245. Gastritis and peptic ulcer disease in nursing facility residents. Regimen 1997;5(5):1-4. 246. Monitoring constipation and diarrhea in nursing facility residents. Regimen 1997;5(6): 1-4. 247.*Stroke prevention and post-stroke rehabilitation bibliography. J Geriatr Drug Ther 1996;11(2):45-57. 248. * Treatment of Urinary incontinence in the elderly: a bibliography. J Geriatr Drug Ther 1997; 11(3): 61-72. 249. Assessing Cognition and Depression in Nursing Home and Long-term Care Patients. Regimen 1997; 5(7): 1-4. 250. Minimization of Psychoactive Drugs in Nursing Home Patients. Regimen 1997; 5(8): 1-4. 251. Assessing arthritic pain in the frail and elderly nursing home resident. Regimen 1997: 5(9):1-4. 252. Treating arthritic pain with analgesics and non-acetyl salicylates. Regimen 1997; 5(10):1-4. 253. Treating the arthritic patient with NSAIDs. Regimen 1997;5(11):1-4. 254. Arthritic patient pain management.: narcotic analgesics and antidepressants.
Regimen 1997; 5(12): 1-4. 255. Dementia-associated agitation, aggression and disruptive behavior in nursing facility residents. Regimen 1998; 6(1):1-4. 256. Non-pharmacologic treatment of agitation, aggression and disruptive behavior. Regimen 1998; 6(2): 1-4. -32 -
257. Pharmacologic treatment of dementia-associated agitation and aggression. Regimen 1998; 6(3): 1-4. 256. Beta blocker use in nursing facility patients. Regimen 1998; 6(4): 1-4. 257. The use of calcium channel blockers in nursing facility residents. Regimen 1998;6(5):1-4. 258. Hypolipidemic therapy in nursing facility patients. Regimen 1998; 6(6): 1-4. 259. Constipation in the geriatric nursing facility patient. Regimen 1998; 6(7): 1-4. 260. Causes and treatment of diarrhea in the geriatric nursing facility patient. Regimen 1998; 6(8):1-4. 261. Evaluating polypharmacy among nursing facility residents. Regimen 1998; 6(9): 1-4. 262. Polypharmacy-related problems among nursing facility residents. Regimen 1998; 6(10): 1-4. 263. Unnecessary and inappropriate drugs in the nursing facility resident. Regimen 1998; 6(11);1-5. 264. Reducing adverse drug reactions and hospitalizations among nursing facility residents. Regimen 1998; 6(12):1-4. 265. Parkinsonism-related drug therapy in nursing home patients. Regimen 1999; 7(1)@ 1- 4. 266. Causes and treatments of urinary incontinence in nursing facility patients. Regimen 1999; 7(2):1-4. 267. Diabetes mellitus in nursing facility patients: new guidelines for assessment and treatment overview. Regimen 1999; 7(3):1-4. 268. Newer oral hypoglycemics for the diabetic nursing facility resident: acarbose and miglitol. Regimen 1999; 7(4):1-4. 269. Oral agent therapy of type 2 diabetes mellitus in nursing facility residents: metformin, troglitazone, sulfonylureas and repaglinide. Regimen 1999; 7(5/6): 1-4. 270. Osteoporosis assessment, prevention and treatment within the nursing facility. Regimen 1999; 7(7/8):1-4. Via Internet site ncpa.org -33 -
271. Osteoporosis Treatment. Regimen 1999; 7(9/10):1-4 Via internet site ncpa.org 272. Congestive heart failure in nursing facility residents. Regimen 1999; 7(11/12), via ncpa.org 273.* Nonpharmacologic and pharmcologic treatment of dementia-associated agitation, aggression and disruptive behaviors. J Geratr Drug Ther 1999; 12(3):5-28. 274. Congestive heart failure II. Regimen 2000; 8(1/2): 1-4.
275. *Adverse Drug Reactions in Geriatric Nursing Facility Residents. Medscape 2000; 18 Jan issue via medscape.com 276. Fluoroquinolone usage in nursing facility residents. Regimen 2000; 8(3/4):1-4. 277. Arthritic patient pain management in nursing facility residents: assessment. Regimen 2000; 8(5/6):1-4. 278. Arthritic patient pain management in nursing facility residents:Treatment with peripheral analgesics. Regimen 2000; 8(7/8):1-4. 279. Arthritic patient pain management in nursing facility residents: Treatment with nonsteroidal antiinflammatory drugs (NSAIDs). Regimen 2000; 8(9/10):1-4 280.Arthritic patient pain management in nursing facility residents: Moderate to severe pain management-narcotic analgesics and adjunctive agents. Regimen 2000; 8(11/12):1-4. 281. *Arginine monograph . The Natural Pharmacist. (tnp.com) 2000. 282. *Multiple Sclerosis. American Pharmacist 2000; 122(7): 61-67. 283. Preventing falls by pharmacist medication management. Regimen 2001;9(1/2):1-4. 284. *Preventing falls through medication management by the pharmacist. Ga Pharm Quart 2001; 78(1):2,4,7,12, 15. 285. Laboratory assessment of geriatric drug therapy: rationale, regulations and frequency. Regimen 2001;9(3/4):1-4. 286. Cooper JW. Fluid and electrolytes assessment in geriatric patients-Fluids. Regimen 2001;9(5/6):1-4. 287.*Cooper JW. Safe medication use in the older adult. J APhA 2001; 41(suppl1): S46- -34 -
47. 288.Cooper JW. Prevention of adverse drug reactions in older adults. American Pharmacist. 2001:123(12):53-60. 289. Cooper JW. Serum electrolyte assessment in geriatric patients. Regimen 2001; 9(7/8):1-4. 290. Cooper JW. Blood gases and acid-base balance in geriatric patients. Regimen 2001;9(9/10):1-4. 291. Cooper JW. Renal function assessment and urinalysis in geriatric patients. Regimen 2001; 9(11/12):1-4. 292. Cooper JW. Oral drug therapy for type 2 diabetes mellitus in the elderly. Clinical Consult 2001: (4):1-8. 293. Cooper JW. Serum and urine glucose in geriatric patients. Regimen 2002; 10(1 /2);1- 4. 294. Cooper JW. Hematology and hemostasis. Regimen 2002; 10 (3/4):1-4. 295. Cooper JW. Red blood cell formation and hemostasis. Regimen 2002; 10(5/6):1-4. 296. Cooper JW. Drug Levels- A Practical Guide for The Senior Care Pharmacist. Regimen 2002;10(7/8):1-4. 297. Cooper JW. Hepatic Function and Disease Indices in Nursing Home Patients. Regimen 2002;10(9/10):1-4.
298. Cooper JW. Liver Functional Reserve, Drug-Induced Damage and Drug Dosing in Liver Impairment. Regimen 2002; 10 (11/12):1-4. 299-300. Cooper JW. Inappropriate drug use in the elderly: revised Beer’s Criteria for 2003.Regimen 2003; 11(1/2):1-4. And (3/4):1-4. 301. Cooper JW. Burfield AH. Medication Therapy Management (MTM) Strategies for Geriatric Patient Interventions: Medicare Part D Implementation. Ann Long Term Care 2007; 15(7):33-38. 302. Cooper JW, Burfield AH. Potentially Inappropriate Drugs in the Older Adult. for GMCF “drug safety initiative for Ga Academy of Family Practice, 2010 available on-line at Ga Academy of Family Practice web site. www.gafp.org. -35 -
303. Cooper JW, Burfield AH. Non-pharmacologic and Pharmacologic Treatment of Agitation in Dementia for Am. J Ger Pysch Nursing submitted 2010 Book and Educational Media Reviews ( all J.W. Cooper sole author, except where indicated) 1. A Manual of Adverse Drug Interactions. Am J Pharm Ed 1976; 40:323-324. 2. Handbook of Drug Treatment. Am J Pharm Ed 1977; 41:249. 3. Drug Induced Nutrition Deficiencies. Am J Pharm Ed 1977; 41:545. 4. Medication Guide for Patient Counseling, Am J Pharm Ed 1978; 42:241-242. 5.Cooper JW, Francisco GE. Drugs and the Aged. Am J Hosp Pharm 1981;38:131-2. 6. Drug Treatment in the Elderly. J Geriatr Drug Ther 1986; 1: 83. 7. Handbook of Nutrition in the Aged.ibid. 1987;1(4):97-98. 8. Geriatric Pharmacology and Therapeutics. J Geriatr Drug Ther 1987;1(4):101-103. 9. Handbook of Nutrition in the Aged. J Geriatr Drug Ther 1988; 2(4):90-91. 10. Drugs and The Elderly.Geriatr Med Today 1990;3-5. 11. Therapeutics in the Elderly. J Geriatr Drug Ther 1988; 3(2):103-4. 12. Cooper JW, Longe RL. Introduction to Physical Assessment and Clinical Laboratory Medicine. Am J Pharm Ed 1979; 43:324. 13. Cooper JW, Jordan TL. Worst Pills-Best Pills. J Geriatr Drug Ther 1990;4(4):111-112. 14. Pharmacoepidemiology:An Introduction. J Pharmacoepi 1990; 1(2):65-66. 15. Clinical Pharmacology in the Elderly. J Geriatr Drug Ther 1990; 5(1):83-84. 16. USPDI Vol. I and II. J Geriatr Drug Ther 1991;6(1):85-86. 17. About Your Medicines, 6th ed. J Geriatr Drug Ther 1991; 6(2): 87-88. 18. Handbook of Drug Therapy in Liver and Kidney Disease. J Geriatr Drug Ther 1992;7(1): 92-93. -36 -
19. Handbook of Prescribing Medications for Geriatric Patients. J Geriatr Drug Ther 1993;7(3):67. 20. USPDI Vol. I and II. ibid. 1993;7(4):85-86. 21. Drug Prescribing for the Elderly. ibid. 1993; 8(2): 61-62. 22. Geriatric Dosage Handbook.J Geriatr Drug Ther 1993;8(1):89-90. 23. Pharmacotherapy: A Pathophysiologic Approach, 2nd. ed. ibid. 1994;8(3): 95-96. 24. USPDI Vol.I and II. ibid. 1994;8(4):83-84. 25. Exploring Geriatric Therapeutics Vol.1, programs 1-3. J Geriatr Drug Ther 1994;9(2):77. 26. Practical Handbook of Psychopharmacology. ibid. 1995;9(4):67-8.
27. Home Health Care Practice. ibid. 1995;9(3):85-6. 28. Antimicrobial therapy in the elderly, ibid. 1995;10(1):79-80. 29. Therapeutics in the elderly, 2nd ed., ibid. 1996;10(2):73-74. 30. AGS complete guide to aging and health, ibid.1996;10(4):71-72. 31. Merck manual of geriatrics, 2nd ed., ibid. 1996;11(1):71. 32. Cooper JW. Therapeutics in the elderly, 3rd ed., Am J Health-Syst Pharm 2001; 58, 1459. Book Chapters (BC-x) (NOTE: separate chapters those * are in books listed below) 1. Cooper JW, "Problems in the Real World--The Patient," NIH Workshop on Pharmacology and Aging Proceedings, September 15-16,1977, Bethesda,Maryland, DHEQ Pub. No. (NIH) 78-353. 2. Cooper JW, "Drug-Related Problems and the Elderly," chapter in Eldercare: A Guide to Clinical Geriatrics, by M. O'Hara-Devereaux and L. H. Andrus.New York: Grune and Stratton, 1980. 3. Cooper JW, "Monitoring Drug Therapy in an Extended Care Facility," book chapter in Problems in Geriatric Drug Therapy. Menlo Park, CA.Addison-Wesley Pub. Co., 1981. 4. Cooper JW, "Consultant Pharmacy," in Smith and Brown (Ed) Handbook of Institutional -37 -
Pharmacy Practice, Williams and Wilkins, Baltimore, 1985. 5. Cooper JW, "Antihistamines and Decongestants in The Treatment of Chronic Rhinitis", New England and Regional Allergy Proceedings Vol. 1,1984. 6. Cooper JW, "H-1 Blockers, Classical Antihistamines" in "H1 and H2 Histamine Receptors" G.Settipane editor, Ocean Side Pub., Inc. Providence, RI 1988. 7. Cooper JW, "Pharmacy Service to Long Term Care Patients" in T.R. Brown Handbook of Institutional Practice, ASHP 1992. 8. Cooper "Classical Antihistamines and Decongestants in the Treatment of Chronic Rhinitis"in Rhinitis, G. Settipane, ed., 2nd. ed., 1991. 9. *Cooper JW, Geriatric drug therapy interventions in, Cooper JW. (ed./co-au.) Geriatric drug therapy interventions, Pharmaceutical Products Press, 1997. 10. *Cooper JW, Wade WE. Constipation in the Geriatric Patient@, in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997. 11. *Cooper JW, Wade WE. Diarrhea in the Geriatric [email protected] Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997. 12. *Wade WE, Cooper JW. Gastroesophageal reflux disease in the elderly@,in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997. 13. *Wade WE, Cooper JW. Inflammatory bowel disease in the elderly patient@,in Gastrointestinal Drug Therapy in the Elderly. Pharmaceutical Products Press, Binghamton, NY, 1997.
14. *Wade WE, Cooper JW. Managing hyperuricemia and gout in the geriatric patient@ in Chisholm MA, Cooper JW (eds.), Musculoskeletal drug therapy for geriatric patients. Pharmaceutical Products Press, Binghamton, NY, 1999. 15. * Cooper JW, Groce J. Antithrombotic therapy in the long-term care setting: reassessing the risk of deep venous thrombosis and pulmonary embolism in the acutely ill medical patient, in Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16. ASCP, Alexandria VA, 2001 16. *Cooper JW, Groce J . DVT/PE Prophylaxis in medically ill patients: a new avenue of -38 -
clinical management in the long-term care setting, in Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16. , ASCP, Alexandria VA, 2001 17. *Groce J, Cooper JW. The pharmacoeconomics of low-molecular weight heparins: getting the most bang for the health care buck, in Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16., ASCP, Alexandria VA, 2001. 18. Cooper JW. Adverse drug reactions, medication errors and chemical restraints, chapter in Braun JL and Capezutti L (eds), Litigating Injuries in the Elderly: A Legal medical Reference Guide to Nursing Homes and Assisted Living Facilities, 2002. 19. Cooper JW. The Role of Expert Witnesses:Pharmacists, part of chapter in Braun JL and Capezutti L ibid. Books, Monographs and Manuals (B-x) all JW Cooper author, unless otherwise noted 1. Cooper JW, Gerson CK, Smith CA. Conducting an Inservice Training Program, American Pharmaceutical Association, Washington, D.C., 1981 2. "Drugs and the Older Adult", Georgia Center for Continuing Education, Athens,1982, 2nd ed. 1989. 3. "Process Guide to Clinical Orientation", UGA Press, 1980. 4. "Community and Nursing Home Drug Monitoring Guidelines-1990" , Consultant Press, Watkinsville, GA.; 1993 edition 5. " Drug Related Problems in Geriatric Nursing Home Patients", Haworth Press, New York, NY, 1991. 6. McCombs J, Cooper JW. "Externship Manual"College of Pharmacy UGA, (5th ed.), 1989 Ed. 2-4 1976-85. 7. Perri M, Cooper JW,"Alzheimer's Counseling Guidebook for Pharmacists ", Medical Publishing Enterprises, 1994. 8. Cooper JW, Ouslander JG, Small RE, Oles KS, (eds.) "Benign Prostatic Hyperplasia: Treatment Advances", American Pharmaceutical Association, Washington DC, 1992.
9. Cooper JW, Piepho RW, "Cost-effective Management of Benign Prostatic Hyperplasia", SCP Communications, New York, NY 1994. -39 -
10. Cooper JW, Gordon N, Radovich C, Siegal AP. "The Recognition and Management of Depression in the Long-term Care Institution", NCM Publishers, Inc. New York, NY 1995.(and videotape) 11. Cooper JW, Davis S, Miller C. "Management of Lower respiratory Tract Infections in the Elderly Long-Term Care Facility Resident". Health Sciences Institute, Philadelphia, 1995. 12. Cooper JW. (ed.) "Antiinfectives in the Elderly". Pharmaceutical Products Press, Binghamton, NY, 1995. 13. Cooper JW. (ed.) "Antivirals in the Elderly". Pharmaceutical Products Press, Binghamton, NY, 1996. 14. Cooper JW. (ed./author) "Urinary Incontinence in the Elderly: Pharmacotherapy Treatment." Pharmaceutical Products Press, Binghamton, NY, 1997. 15. Cooper JW. (co-author and ed.). "Geriatric Drug Therapy Interventions". Pharmaceutical Products Press, Binghamton, NY, 1997. 16. Cooper JW, Wade WE. (co-authors and co-eds.) "Gastrointestinal Drug Therapy in the Elderly." Pharmaceutical Products Press, Binghamton, NY, 1997. 17. Carvalho MG, Cooper JW, Fossen MS. Lieberman JA, Wise MG. Rational therapy: persistent anxiety. ICPRx, Boston, MA, 1997. 18. Cooper JW, Kurlowicz LH, White P. Management of depression in elderly residents of long-term care facilities. Medical Education Systems, Inc., Philadelphia, PA, 1997. 19. Cooper JW, Hooker RS. Minimizing NSAID-related GI toxicity. Supplement to Drug Topics, 17 Feb 1998. 20. Cooper JW, Hughes AC. Headache Assessment and Treatment, Consultant Press, Watkinsville GA1999. 21. Cooper JW, Hughes AC. Polypharmacy Management in the Older Adult, ibid. 1999. 22. Cooper JW (editor and co-author) Diabetes mellitus in the elderly, Haworth Press, 1999. 23. Chisholm M, Cooper JW. Musculoskeletal disease drug therapy for geriatric patients, Haworth Press, Binghamton, NY, 1999. 24. Armstrong EP, Cooper JW. (Eds.) Atypical antispychotics: administrative issues and -40 -
cost differentiation, Medical Education Systems, Philadelphia, 1999. 25. Bykowski KJ, Cooper JW, Narayan P, Stello B. Rational therapy: Pharmacologic management of benign prostatic hyperplasia, Institute for Integrated Healthcare, Wellesley, MA 1999 26. File TM, Cantrell HF, Cooper JW. Antiinfective therapy guide-2000. Antibiotic puzzle,
Inc. Greenville, SC, 2000., 2001 and 2002 editions 27. Cooper JW, Groce J, Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Supplement D to The Consultant Pharmacist 2001; vol. 16. (see chapters in previous section), ASCP, Alexandria VA, 2001 28. Cooper JW. Consultant Pharmacy and Long Term Care Patient Certification Program: An Introduction and Clinical Tools for the beginning Consultant Pharmacist. Consultant Press, 1200 Colliers Creek Rd. Watkinsville, GA 30677-1867. Available solely through www.cooperconsultantpress.com til 2013- see 34 below for latest edition. 29. Cooper JW, Burfield AH. Geriatric Medication Therapy Management Certificate Program:Drug Therapy Guide- a practical guide and clinical tools for the pharmacist. ibid. 30. Cooper JW, Burfield AH. Laboratory tests and Physical Assessment for Drug Therapy. In the Older Adult -2012 course thru UFl College of Pharmacy CPE Dept. at http://cpe.pharmacy.ufl.edu/. Book thru www.cooperconsutlantpress.com 31. Cooper JW. Antiinfectives and Immunizations Review-2011, ibid. 32. Cooper JW. Infectious Disease Review-2011, ibid. 33. Cooper JW. Get Smart(er): Know Your Antibiotics & Vaccines-A Basic Primer for Pharmacists-2013 course thru UFl College of Pharmacy CPE Dept. at http://cpe.pharmacy.ufl.edu/. Book thru www.cooperconsutlantpress.com. 34. Cooper JW. Consultant Pharmacy and Long-Term Care Patients- Self-Study Program-2013 course thru UFl College of Pharmacy CPE Dept. at http://cpe.pharmacy.ufl.edu/. Book thru www.cooperconsutlantpress.com. Videotapes- 1. Training Senior Center Workers to Assist the Elderly with their Medications. Georgia Center 1980 (four one-half hour tapes) to be used with "Drugs and the Older Adult"- please see book no.2 above. -41 -
2. Assessing Medications in the Elderly Patient. Medical University of South Carolina, 1987, 16 hours. 3. Recognition and Management of Depression (see 10. books and monographs above) 0.5 hours 4. Drug-Related Problems at All levels of Care. Mercer University Southern School of Pharmacy, 1995, 0.5 hours. Audiotapes- 1. Cooper JW, Cobb HH. Clinical outcomes in pharmacy research. Medical Outlook, The Cortlandt Group, Ossining, NY, 1994. 2-10. Presentations at ASCP and NARD Meetings on Lab Tests and Case Studies, and antiinfectives, and Falls 1992, 1993,1994, 1995, 1996, 1997, 1998, 2000 and 2001 11. The First Peter P. Lamy Memorial Lecture, ASCP, November, 1999. CD-ROM 1. Grossberg GT, Cooper JW. Managing agitation and preventing falls in the elderly. Medical Communications Media, Inc. Langhorne, PA, 1997.
2. Cooper JW. Treatment of RTIs and UTIs with Fluroroquinolones. Pharmerica via Bayer Grant, 2002. Used in teleconference to 400+ LTCFs. WEB-CE and Pod-Casts Snader T, Cooper JW. Undertreatment of geriatric pain. www.ascp.com, 2000 Cooper JW. EENT Infections, TB, UTIs and Bone and Joint Infections to Non-traditional Pharm.D. Program, Mercer University SouthernSchool of Pharmacy and UGa, 2001-2006 Cooper JW, Beier M, Cranmer K. Palliative Care and End of Life Issues in Long Term Care Facilities, www.ascp.co, 2001 Cooper JW, Beier M, Assessment and Appropriate Treatment of Geriatric Pain: A Call to Action, www.ascp.com, 2000. Cooper, JW. Consultant Pharmacy and Long Term Care- see book 28 above.2010 Cooper JW. Geriatric Drug Therapy- A Guidebook for Pharmacists to prepare for Medicare Part D Counseling and Interventions, see book 29 above., 2010 -42 -
Cooper JW, Lippik I. Improving AED Therapy in the Older Adult. MCM Pod-cast, 2010. at www.cmecorner.com. Cooper JW, Burfield AH. LTC Pain Management Case 2011 at www.utcop.edu. Cooper JW. CGP-preparatory Course-2010, two cases for 50 hour Self-Study Program at www.ccgp.org. Presentations Abstracts/National(*) , Regional(**) or International(***) Research (PAx) ** 1. Cooper JW, Honigberg IL. Synthesis of Cyclic Amino Acids, Southeastern Medicinal Chemistry Society, Athens, March 1967. * 2. Cooper JW, Fish K, Wellins I and Loomis M, "A Seven Nursing Home Study of the Incidence of Potential Drug Interactions,"to Academy of General Practice, APhA, August, 1974, Chicago, Illinois, Proceedings. * 3. Walchle RC, Cooper JW, "Incidence of Potential Drug-Related Problems in Patients Entering a Small Community Hospital," to Academy of General Practice, APhA, August, 1974, Chicago, Illinois, Proceedings. * 4. Cooper JW, "Continual Clinical Pharmacy I: A Method to Detect Drug-Related Problems in the Small Community," to the American College of Clinical Pharmacology, May, 1975, Atlantic City, NJ * 5. Cooper JW, Campbell NA, "Community-Hospital Practitioner Consultation," to Academy of General Practice, APhA, July, 1973, Boston, Massachusetts, Proceedings. * 6. Cooper JW, "Ideas That Work in the LTCF," American Pharmaceutical Association Annual Meeting, Academy of General Practice, Long-Term Care Section, May 17, 1977, New York, New York, Proceedings. * 7. Lewis KP, Cooper JW, McKercher PL, "Pharmacist Effect on Digoxin Usage and Toxicity,ASHP Mid-Year Clinical Meeting, December 8,1976, Anaheim, California,
Proceedings. NOTE; KP Lewis was awarded the ASHP Student Research award in 1977 * 8. Walchle RC, McKercher PL, Cooper JW, "Patient Drug Histories by Criterion Selection,ASHP Annual Meeting, May 18, 1977, New York, New York, Proceedings. * 9. Birmingham BK, Rhodes CT, Green DS, Cooper JW, "Percutaneous Absorption of Salicylic Acid in Rabbits," Academy of Pharmaceutical Sciences, May 16, 1977, New York, New York, Proceedings. -43 -
* 10. Cooper JW, "Real World Drug Problems of the Elderly Patient,"Invitational Paper to Workshop on Pharmacology and Aging, National Institutes of Health and Aging, September 15, 1977, Proceedings. * 11. Cooper JW, "Iatrogenic/Self-Induced Hyperkalemia in an Elderly Female," to Academy of Pharmacy Practice, May 17, 1978, Montreal, Canada,Proceedings. * 12. Cooper JW, "Consultant Pharmacist Effect on Drug Usage in the Long Term Care Facility," American Society of Consultant Pharmacists Annual Meeting, November 2, 1978, Atlanta, Georgia, Proceedings. * 13. Williamson DH, Cooper JW, Kotzan JA, "Consultant Pharmacist Effect on Antihypertensive Therapy in the Long Term Care Facility," American Society of Hospital Pharmacists Mid-Year Clinical Meeting, December 5, 1978, San Antonio, Texas, Proceedings. * 14. Cooper JW, "Drug Regimen Review in the Elderly Patient," American Society of Consultant Pharmacists, November 16, 1979, Dallas, Texas, Proceedings. * 15. Wilcher DE, Cooper JW, "Consultant Pharmacist Effect on Analgesic Antiinflammatory Usage in Geriatric Long-Term Care Facility," ASHP Mid-Year Clinical Meeting, December 3-4, 1979, Las Vegas, Nevada,Proceedings. * 16. Tsai A, Cooper JW, McCall CY, "Consultant Pharmacist Effect on Hematopoietic and Vitamin Therapy in a Geriatric Long-Term Care Facility," ASHP Mid-Year Clinical Meeting, December 3-4, 1979, Las Vegas, Nevada, Proceedings. * 17. Lawler RS, Cooper JW, Kotzan JA, "Consultant Pharmacist Input to Treatment of Urinary Tract Infections in a Geriatric Long-Term Care Facility," presented to ASHP Mid-Year Clinical Meeting, December 3-4, 1979, Las Vegas, Nevada, Proceedings. * 18. Cooper JW, Francisco GE, "Consultant Clinical Pharmacist Effect on Psychotropic Usage in Long-Term Care Facility Geriatric Patients," ASHP Mid-Year Clinical Meeting, December 3-4, 1979, Las Vegas, Nevada, Proceedings. ** 19. Marcantonio SM, Cooper JW, McCall CY, Mandell GL,"Dexamethasone Prevention of Cisplatinum Nausea and Emesis," 12th Annual Southeastern Regional Conference on Hospital Pharmacy, March 7, 1981. ** 20. Wilcox JT, Francis WR, Francisco GE, Cooper JW, "Drug Information in U.S.Army Hospitals," ibid. -44 -
** 21. Griffin DL, Francis WR, Francisco GE, Cooper JW, "Pharmacist Contribution to Home Health Care," ibid. ** 22. Pink LA, Cooper JW, Francis WR, McCall CY, "Pharmacist Input to Digoxin Usage and Effect in a Geriatric Long Term Care Facility," ibid. * 23. Spruill WJ, Cooper JW, Taylor WS, "Pharmacist-Coordinated Pneumonia and Influenza Vaccination Program," ASHP Mid-Year Clinical Meeting, December, 1981, New Orleans, Louisana, Proceedings. * 24. Griffin DL, Francisco GE, Cooper JW, Francis WR,"The Pharmacist in Home Health Care," ibid. * 25. Wade WE, Cobb HH, Cooper JW, "Drug-Related Problems in a Geriatric Ambulatory Population", ASHP Midyear Clinical Meeting, December 1983, Atlanta, Proceedings. * 26. Cooper JW, McCall CY, Longe RL, Braucher CL,"The Use of Slow Scan Television for Small Group Therapeutics Lectures." Am J Pharm Ed. 48:80, 1984. ** 27. Durrence CE, May JR, DiPiro JT, Cooper JW. Drug Interactions in Surgical Patients, 15th Annual Southeastern Conference for Hospital Pharmacy, Athens, Georgia, March 1982. * 28. Cooper JW, "Drug Related Problems in a Geriatric Long Term Care Facility," 18th Annual ASCP Meeting, Orlando, 1984. * 29. Cooper JW, Cobb HH, Shepherd MD, "Drug Discards in Two Georgia LTCFs," ASHP Mid-year Clinical meeting, Dallas, Dec.1984. ** 30. Miller MJ, Cooper JW, Erwin WG, "Efficacy of a Transdermal Patch Product in Geriatric Long Term Care Patients with Angina", Sixteenth Annual Southeastern Conference for Post Graduate Pharmacy Education and Training, (SECPGPET) 1985. ** 31. Morton MR, Cooper JW, Spruill WJ, Fincham JE, "Pnuemococcal Vaccine Efficacy in a Geriatric LTCF Population, ibid. March 1986. * 32. Cooper JW, "Transdermal Nitroglycerin Efficacy in Ambulatory Geriatric Patients". ASHP Mid-year, New Orleans, December 1985. * 33. Cooper JW, "Nursing Home Admission Orders and The Consultant Pharmacist" ASCP Meeting, New Orleans, November, 1986. * 34. Doyal LE, Cooper JW, "Cost-Justification of the Clinical Pharmacist in a Community Mental Health Center", ASHP Mid-Year Meeting, Las Vegas, December, 1986. -45 -
** 35. Mallet L, Cooper JW, Wade WE. "Anemia Detection, Prevalence and Treatment Outcome in a Geriatric LTCF Population". Abstract of 17th SECPGPET meeting, March 1987. * 36. Cooper JW. "Constipation in the Elderly Patient". ASCP Mid-year meeting, San Diego, May, 1987. * 37. Cooper JW and Department faculty, "Pharmacy Practice Research", 1980-1987," to
American Association of Colleges of Pharmacy (AACP), Charleston, July 1987. ** 38. Cooper JW, "How to Deal with the Nursing Home Patient" to region III AACP/NABP Meeting, Biloxi, August, 1987. *** 39. Cooper JW," The Development of Consultant Pharmacy in the United States of America", to Second International Conference on Professional Orientation, Valencia, Spain, November 1987. *** 40. Cooper JW, " Geriatrics Pharmacy Practice Contribution to Nursing Home Care in The United States of America" to Second International Congress on Geriatric Pharmacotherapy and Nutrition, Alicante Spain, November 1987. * 41. Morton MR, Cooper JW," Digoxin-Erythromycin Interaction" to ASHP Mid-year Clinical Meeting, Atlanta, December 1987. * 42. Mallet L, Cooper JW, " Anemia Development Prediction to ibid. ** 43. Cooper JW, "Geriatric Pharmacy Research at the University of Georgia and Medical College of Georgia", to University System Advances in Geriatrics and Gerontology, Athens, March, 1988. ** 44. Cooper JW, "Drug-Related Problems in the Elderly", to ibid. * 45. Cooper JW, Consultant Pharmacist Impact in Health Care: Past, Present and Future, to the American Pharmaceutical Association, Atlanta, March, 1988. * 46. Mallet L, Cooper JW, "Effect of Intensive Pharmacist Rounding on Nursing Home Care", ASHP Mid-Year Clinical Meeting, Dallas TX, December, 1988. *** 47. Cooper JW, "The Physician and Pharmacist Roles in Geriatric Patient Compliance", Hawaiian Medical, Pharmacists and Hospital Pharmacists Societies, Honolulu, September 1989. *** 48. Cooper JW, "Geriatric Pharmacy Education in the USA", 3rd International Congress on Geriatric Pharmacotherapy, Alicante, Spain, October 1989. -46 -
* 49. Morton MR, Spruill WJ, Cooper JW, Fincham JE, Respiratory infections in Nursing Home Patients Receiving Pnuemococcal and Influenza Vaccines, American Geriatrics Society, May, 1990. * 50. Cooper JW, Jordan TL, Psychotropics and Falls in Nursing Home Patients. ibid. * 51. Cooper JW, "Psychoactive Drug Effects in a 200 Geriatric Nursing Home Population" to Pharmacy Science Liaisons of The Upjohn Company, February 1990. ** 52. Jordan TL, Cooper JW, "Adverse Events of Psychotropic Drugs in a Geriatric Nursing Home Population" to Southeastern Postgraduate Education Conference, Athens, April 1990 and American Society of Consultant Pharmacists, San Antonio, November, 1990. ** 53. Gordon JE, Cooper JW, "Diabetes Treatment and Complication Outcomes in a Geriatric Nursing Home- A Three-Year Study", to ibid. ** 54. Cooper AE, Cooper JW, "Diuretic Usage and Electrolyte Effects in a Geriatric
Nursing Home," ibid. *** 55. Cooper JW, "The Development of the Doctor of Pharmacy Degree in The United States of America" to Korean Society of Hospital Pharmacists, Seoul, October 1990. *** 56. Cooper JW, "Consultant Pharmacists Effect on Diabetes Mellitus Treatment Outcomes in Two Nursing Facilities", American Society Consultant Pharmacists Annual Meeting , Montreal, November, 1991; Georgia Society of Hospital Pharmacists, Atlanta, 1992 * 57. " Drug-Related Costs and The Elderly" to the Senate Special Committee on Aging, Invited Expert Witness Testimony at the request of Senators David Pryor and Wyche Fowler, Atlanta, April 1992. *** 58. Cooper JW, "Using 'Prove-it' to Document the Value of Your Clinical Services", ASCP, Montreal, Canada, November, 1992 *** 59. Cooper JW, "Geriatric Pharmacotherapy Issues in the United States of America", Fourth International Congress on Geriatric Pharmacotherapy and Nutrition, Valencia, Spain. 1992 *** 60. Cooper JW, Bristol Royal Health Care Trust Department of Pharmacy, "Clinical Pharmacy Services in Acute and Long Term Care", Bristol, UK, 25 Aug 1992 *** 61. Cooper JW, Bristol and Weston UK Health Care Districts, "Pharmacy Care in the -47 -
Community: Experience from the USA", 27 Aug 92 *** 62. Cooper JW, The School of Pharmacy, University of London,"Impact of the Consultant Pharmacist on Health Care", 2 Sep 92 *** 63. Cooper JW, Royal Pharmaceutical Society of Great Britain, Scottish Headquarters, Edinburgh, Lothian Pharmacy Practice Group, "Consultant Pharmacist Contributions to Health Care in the United States of America",3 Sep 92. *** 64. Cooper JW, British Pharmaceutical Conference, Geriatric Pharmacy Association Meeting, Birmingham, " Remarks on Consultant Pharmacist Activities at All Levels of Care", 9 Sep 92 * 65. Cooper JW," Pharmacotherapy of Depression in Nursing Home Patients-15 years of Pharmacoepdemiologic Results", Am. Soc. of Cons.Pharmacicts, Orlando, November, 1992. * 66. Cooper JW, "Pharmacotherapy Recommendations from Monthly Drug Regimen Reviews in a Geriatric Nursing Facility: A One-Year Study" to American College of Clinical Pharmacy Meeting, San Diego, CA February, 1994 *** 67. Cooper JW," Consultant Pharmacy in the United States of America" to the 3rd International Congress On Unit_Dose Distribution Systems, Alicante, Spain, June 1994. *** 68. Cooper JW, "Drug Concerns in the the Elderly Patient" to ibid. *** 69. Cooper JW,"Pharmaceutical Care in the United States of America: Practical Outcome Measures" to Universities of Valencia, Alicante, Cordoba, Granada and Seville and Jaen Pharmacists Society, Spain, June 1994. * 70. Cooper JW, "Consultant Pharmacist Effect on NSAID Gastropathy over a 5-year Period" to ASCP Meeting, November, 1995 * 71. Cooper JW, "COPD Case Study" to ibid. * 72. Cooper JW, "Oral Antiviral Safety in the Treatment of Herpes Zoster", ibid.
** 73. McRae A, Cooper JW. "Nonaggressive short-term nutritional supplementation in a nursing home population" to Southeastern Post-graduate Conference. Athens, GA, May 1996. *** 74. Cooper JW. Fall risk assessment and reduction within the nursing facility, ASCP meeting abstract p.406-7,, Nashville, November 1996. -48 -
*** 75. Cooper JW. Psychoactive-associated fall injury assessment, costs and reduction within the nursing facility, ibid., abstract #23. *** 76. Cooper JW, Chapman N. Fall risk assessment within the hospital setting, ibid., November 1996. *** 77. Cooper JW. Approaches for reducing psychotropic-related fall injuries in long term care: treatment of anxiety and agitation, ibid. *** 78. Cooper JW. Pharmaceutical care and the role of the pharmacist in arthritis therapy, ibid. *** 79. Cooper JW. Reducing psychotropic-related falls and injuries, agitation, aggression and anxiety in geriatric patients, to American Medical Directors Association, Phoenix, February, 1997. *** 80. Cooper JW. Buspirone conversion effect on reducing psychoactive-associated falls and fall-related injuries and dementia-associated agitation and aggression in long-term care patients to American Geriatrics Society and American Federation for Aging Research 1997 Annual Scientific Meeting, Atlanta, May, 1997. ***81. Cooper JW. A Pharmacoeconomic analysis of buspirone conversion effect on fall and drug costs and agitation management, to the National Association of Directors of Nursing Administration/Long Term Care, Austin, June 1997. **82. Janampally R, Cooper JW, et al. Evaluation of the treatment of depression and dementia in a geriatric nursing facility, to 28th Southeastern Residency Conference, Athens, May, 1997. **83. Cooper JW. Diabetes Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997. **84. Cooper JW. Depression Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997. **85. Cooper JW. Falls and Agitation Treatment Outcomes. Tennessee Society of Consultant Pharmacists, Nashville, August, 1997. **86. Cooper JW. Psychoactive medication related falls. Ohio Medical Association, Columbus, August, 1997. *87. Cooper JW. Reduction of Falls, Injuries and Agitation in the Nursing Home, National Conference of Geriatric Nurse Practitioners, San Francisco, September, 1997. *** 88. Cooper JW. Fall Risk Assessment and Reduction within The Nursing Facility, World -49 -
Congress of Gerontology, Adelaide, August, 1997 Accepted, unable to present.
* 89. Cooper JW, Wade WE. Pharmacist interventions regarding NSAID therapy in a geriatric nursing facility. American College of Clinical Pharmacy, Cincinnati, November 1998, Pharmacotherapy 1998;18:1771.and 1999 University System of Georgia Research Symposium, Augusta, March 1999. *90. Cooper JW. Osteporosis interventions in a nursing facility: calcium intake assessment and supplementation over a one-year period. American Society of Consultant Pharmacists, Seattle, November 1998. **91. Cooper JW. Secondary Stroke Prevention Interventions in a Nursing facility Population: A One-year Study, 1999 University System of Georgia Research Symposium, Augusta, March 1999. **92. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Calcium Intake Assessment to ibid. **93. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Dietary Calcium Supplementation Trial to ibid. **94. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Pharmacologic Calcium Supplementation Results to ibid. **95. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Hormone Replacement Results to ibid. **96. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Alendronate Outcomes to ibid. **97. Cooper JW. Osteoporosis Interventions in a Nursing Facility: Calcitonin Nasal Spray Outcomes to ibid. ***98. Cooper JW. Reducing geriatric adverse drug reactions in nursing facility patients to American Societies of Health-System Pharmacists (December) and Consultant Pharmacists (November), 1999. ***99. Cooper JW. Drug-associated appetite and weight changes in long-term care residents: a 5-year study, Long-Term Care Visiting Faculty Program, St. Petersburg, November, 1999. **100. Cooper JW. Prevention of geriatric adverse drug reactions. Grand Rounds via Videoconference to University of Texas Health Center-affiliated hospitals, January, 2000. -50 -
**101. Cooper JW. Advances in Fluoroquinolone Therapy to South Carolina Advanced Nurse Practice Institute, Charleston SC, February, 2000 **102. Horner MR, Cooper JW. Psychotropics, Fall and Hospitalization Risk to Southeastern Postgraduate Conference, Athens, April, 2000. *** 103. Cooper JW. Pharmacoeconomics of Geriatric Pain, to ASCP Meeting, Las Vegas, May, 2000.
*** 104. Cooper JW. Secondary Stroke Prevention in a Nursing Faciliy Population:A One- Year Study to the American Geriatrics Society/.American Federation for Aging Research Meeting, Nashville, May 2000 *** 105. Cooper JW. Special Drug Considerations in the Geriatric Patient, Lamda Kappa Sigma National Meeting, Houston, August 2000 (4 hours) **106. Cooper JW. Safe medication use for the older adult (3 hours) to Northeast Georgia Medical Senior Wellness Seminar, Gainesville, June, 2000. ** 107. Cooper JW. Avelox in URTIs, Atlanta, March, 2000. *108. Cooper JW. Hypolipdemic therapy, Columbus, February, 2000. *** 109. Cooper JW. Pinnacle Award Acceptance Speech, Canadian Embassy, Washington, DC, June, 2000. ** 110. Cooper JW. Appropriate analgesic treatment in the older adult., GPhA meeting, Amelia Island, Florida, June, 2000. **111. Cooper JW. Improving medication use in seniors. Savannah area professional groups, July, 2000. ** 112. Cooper JW. Geriatric Research Update. American Medical Directors Association, Georgia Chapter meeting, Callaway Gardens, July, 2000. ** 113. Cooper JW. Optimal Pain management for the geriatric patient. Miss. Soc. Cons. Pharm., Jackson, October, 2000. ***114. Cooper JW. Interactive case management of pain in the senior care patient. American Society of Consultant Pharmacists (ASCP), Boston, November, 2000 (videotape and slides to be online at ASCP.com) ***115. Cooper JW. New advances in treatment of type 2 diabetes mellitus. Ibid. speaker and panel moderator. -51 -
***116. Cooper JW. Treatment of depression in geriatric nursing facility residents. Ibid. speaker and session moderator. ***117. Cooper JW. NSAID interventions in senior care recipients to ASCP, November, 2000. *** 118. Cooper JW. Are beta blockers more poorly tolerated in the elderly patient? Invited presentation to industry advisory panel at the American Heart Association meeting, New Orleans, November 2000. ***119. Cooper JW, Horner MR. Psychotropic load, falls and hospitalization. Amer. Soc. Health Sys Pharm Mid-year clinical meeting, Las Vegas, December, 2000, abstract 511E *** 120. Cooper JW. NSAID and platelet-affecting interventions in geriatric patients to ibid. *** 121. Cooper JW. Drug treatment issues in patients with dementia. Invited participant to Joint Conference on Legal and Ethical Issues in the Progression of Dementia, UGa Law
School, December, 2000. ** 122. Cooper JW. Reducing Psychotropic-related falls in nursing facility residents. Georgia geriatrics Society, Atlanta, January 2001 and Ga. ASCP Chapter, February, 2001. **123. Cooper JW. Drug-related Problems in Older Adults-Consulting opportunities for Pharmacists, to Michigan Pharmacists Association, Dearborn, MI, February, 2001 *** 124. Cooper JW. Psychotropic Issues in Geriatric Patients, to National Psychiatric Practitioners Conference, Athens, GA, February, 2001 *** 125. Cooper JW. Psychotropic Polypharmacy Case Management to ibid. ** 126. Cooper JW. Pain management for the older adult. Florida Pharmacists Association, Destin, February, 2001. ***127. Cooper JW. Safe Medication Use in the Older Adult. American Pharmaceutical Association, San Francisco, March, 2001 ***128. Cooper JW. Drug-related Problems in an Ambulatory Adult Day Care and Senior Citizen Center Population, ibid. ***129. Cooper JW, Wade WE. Pharmacist intervention in geriatric NSAID usage: Outcomes, to Drug Information Association, Savannah, March 2001 ** 130. Cooper JW. Adverse drug reactions in a medicaid population. Georgia medical -52 -
Care Foundation, Atlanta, March, 2001. ** 131. Cooper JW. Liver function tests and assessment in a geriatric population. Wisconsin Society of Pharmacists , April, 2001. ** 132. Cooper JW. Medication assessment and use in dementia. Alzheimer’s Association of Georgia, Atlanta, February, 2001. **133. Cooper JW. Encouraging safe medication use in assisted living residents. Huntcliffe Summit, Atlanta, April, 2001. *** 134. Cooper JW. Pain management in the cognitively impaired adult. American Society of Consultant Pharmacists, Washington, DC, May 2001. **135. Cooper JW. Behavioral management and psychotropic drugs in dementia. Kentucky Long-Term Care Nurses Association, Louisville, KY, May 2001. **136. Cooper JW. Fall and osteoporosis risk intervention. Pharmerica conference, Hendersonville, KY, June, 2001. **137. Cooper JW. Fall prevention in the elderly. Kentucky Pharmacists Association, Lexington, and Ga. ASCP chapter, Atlanta, June, 2001. *** 138. Cooper JW. Pain management issues in the older adult. Joint Commission on Accreditation of Health Care Organizations Pain Summit, Phoenix, AZ, June, 2001. ***139. Cooper JW. Assessment and treatment of non-malignant pain in the older adult. Grand Rounds, Howard University School of Medicine, Washington, DC, May, 2001. ** 140. Cooper JW. Fall and injury prevention in nursing facility residents. SC ASCP chapter, Columbia, July, 2001. And Auburn CE Programs, August, 2001. **141. Cooper JW. Safe medication use for the older adult. Colorado Pharmacists Assoc.
August and Iowa Pharmacists, September, 2001. ***142. Cooper JW. Perioperative pain management outcomes. American College of Surgeons, New Orleans, October, 2001. ***143. Cooper JW. Development of safe medication use systems for adults. National Community Pharmacists Association, Philadelphia, October, 2001. ***144. Cooper JW. Osteoporosis, falls and injury interventions. Mississippi Society of Consultant Pharmacists, Jackson, October, 2001. -53 -
***145. Cooper JW. Pain management in palliative care. ASCP, Chicago, November, 2001. ***146. Cooper JW. Advanced concepts in geriatric problem solving. ASCP, Chicago, November, 2001. **147. Cooper JW. Infectious disease overview. Mercer University School of Medicine, family practice dept. Grand Rounds, Macon, September, 2001. ***148. Cooper JW. Psychotropic management issues in the geriatric patient. American Society of Health-System Pharmacists, New Orleans, December, 2001. ***149. Cooper JW. Drug-related problems in older adults- consulting opportunities for pharmacists to ibid. ***150. Cooper JW. Cardiovascular implications and COX-2s to Managed Health Care Associates at ASHP meeting, New Orleans, December, 2001. ** 151. Cooper JW. Safe Medication Use in the Older Adult. Sunrise Assisted Living Caregivers, Atlanta, 7 Jan 02. **152. Cooper JW. Preventing Medication Errors in Long Term Care. Sunscript LTC Meeting, Atlanta, 15 Jan 02. **153. Cooper JW. Improving drug use in assisted living residents. Legacy link, Gainesville, Ga 7 Feb 02. **154. Cooper JW. Advanced concepts in geriatric drug therapy problem-solving. Georgia AMDA meeting, Marietta, GA 16 Feb 02. 155. Cooper JW. Pain Management in Cognitively Intact and Impaired Older Adults. Macon Pharmacists Association, 28 Feb 02. ***156. Cooper JW. Development of Medication Management Systems for Assisted Living and Nursing Facility Patients, American Pharmaceutical Association, Philadelphia, 18 Mar 02. ***157. Cooper JW. Drug-related problems in older adults. ibid, 18 Mar 02. **158. Cooper JW. Special drug considerations in older adults (4.5hrs) to Michigan Pharmacists Association, 22 Feb 02. **159. Cooper JW. Advanced concepts in older adults pharmacotherapy problem-solving -54 -
(6 hrs). Pharmacy Society of Wisconsin, 9 Apr 02. **160. Cooper JW. Falls and incontinence to Pharmerica Nursing home nurses, Macon, 22
Apr 02. **161. Cooper JW. Osteoporosis Interventions by the pharmacist. Tennessee Pharmacists Association, Knoxville, 14 May, 19 and 26 June 02. **162. Cooper JW. Fluoroquinolones in respiratory and urinary tract infections. Grady Hospital Pharmacy Clinical Staff, Atlanta, 23 May 02. *163. Cooper JW. Therapeutic advances in COX-2 selective therapy, Georgia Pharmacists Association, Panama City, 8 June 02. *164. Cooper JW. Safe medication use in the older adult project, Georgia Pharmacists Association, Panama City, 8 June 02 and 7 Ga. Citiies over June-Sep 2002. * 165. Cooper JW. Safe medication use in the older adult, Georgia Department of Human Resources, Division of Aging Services, 13 June 2002. 166. *Cooper JW. ADR Intervention in nursing facility patients. Georgia AMDA, ASCP and NADONA Chapters, Reynolds Plantation, GA 12 June 2002. 167. **Cooper JW. Dementia- Delirium-Depression Assessment and Treatment in Nursing Home Patients- Outcomes. Auburn Geriatrics Symposia, Gulf Shores, AL and Lake Guntersville, AL, Julu and August 2002. 168. **Cooper JW. Falls and Urinary Incontinence. Maryland ASCP Chapter, Rocky Gap, 10 Aug 2002. 169. **Cooper JW. Advanced Problem Solving in Geriatric Patients. Mississippi Society of Consultant Pharmacists (6 hrs.). Jackson, 27 Sep 02. 170.*** Cooper JW. Cultural and cognitive differences in pain management. ASCP, Anaheim, 13 Nov 02. 171. * Cooper JW. Infectious disease treatment in geriatric patients. Samford University Geriatrics symposium.(3 hrs) 17 Nov 02. 172. **Cooper JW. Practical Pain Management for older adults. Eldercare pharmacists, Augusta, 6 Dec 02. 173. ***Cooper JW. Practical Pain interventions in elderly patients. ASHP Mid-year Clinical meeting, Atlanta, 11 Dec 02. -55 -
NOTE-averaged 20-70 similar local to regional to national presentations/year 2003-2013. *National;**Regional; ***International Presentation; Otherwise, Local to State Presentation Other invited Lectures and Seminars-(past available on request)-over 1800 presented to pharmacy, nursing, physician, gerontology, consumer, industry as well as interdisciplinary groups in 46 of 50 states and 7 countries outside USA over past 30 years. Graduate Students- NOTE: pharmacy graduate student involvement was discontinued in
1982 to allow development of professional doctoral program courses (Pharm.D.)and post- Pharm.D.fellowships. Continued to serve other disciplines graduate students. 1. M. S. - P. A. Frisk, "Two Pilot Studies to Optimize the Availability and Utilization of Patient Medication Profiles by Linking Community and Institutional Practice Settings," URI, January, 1975. Won 1978 ASHP Award for Achievement in the Professional Practice of Hospital Pharmacy. 2. M. S. - R. C. Walchle, "A Comparison of Pre-Admission Information Retrieval Systems," URI, June, 1976, with Patrick L. McKercher. 3. Ph. D. - P. A. Schwartz, "Some Effects of Renal Disease on Drug Protein Binding," URI, l972-79, with C. T. Rhodes. 4. M. S. - Bruce A. Birmingham, "Percutaneous Absorption of Salicylate," URI, l976, with D. S. Greene. 5. M. S. - R. S. Lawler, "Urinary Tract Antiinfective Usage in an Elderly Population," UGA, 1978. 6. M. S. - D. A. Harrell, "Antihypertensive Therapy in the Long-Term Care Patient," UGA, 1977, with J. A. Kotzan. 7. M. S. - Angela Cheng, "Rational Hematinic Usage in the Elderly Patient," UGA, 1979. 8. M. S. - J. Thomas Wilcox, "Drug Information Services in Army Hospitals," UGA, 1980, with W. R. Francis. 9. M. S. - Donald Griffin, "Pharmacy Input to Home Health in Rural Setting," UGA, 1980, with George E. Francisco. 10.M. S. - Susan Marcantonio, "Dexamethasone in the Prevention of Cancer Chemotherapy Nausea and Emesis," UGA, 1981, with C.Y.McCall 11. M. S. - L.Pink, "Digoxin Usage and Toxicity in the Nursing Home Patient," UGA, 1982,with W.R. Francis. -56 -
12. Ph.D. Committee and Major Professor- Henry H. Cobb, III "Cancer Chemotherapy Stability Considerations", 1987-1995. 13. Ph.D. committee- Wajih Ahmad, RN, MPH, Univ. of Alabama, Birmingham, Dept. of Education, "Malnutrition and Multivitamin and Minerals Supplementation in A nursing Home Population", 1995-6. 14. MS Committee- Rong Jiang MD, Department of Clinical and Administrative Pharmacy, Uga, “Beers Criteria evaluation in a Georgia Medicaid Population”. 2002-3. 15. Burfield AH, PhD in Nursing, Univ. of Central Florida School of Nursing. Visiting Professor for development on Web-CE course on geriatric drug therapy outcomes, 2007. Pharm.D. Students Doctoral Project (Advisor for all Athens students 1981 to 1992) 1. Denise Donnelly (Advisor) "Anemia Prevalence in a Geriatric LTCF", 1986. 2. Spencer Tally (Committee) "Drug Regimen Review in Private vs Public LTCFs," 1986.
3. Tamara James Alexander "Ambulatory Pharmacy Services" Searle Fellowship Mentor, 1990. 4. Marie Annette Chisholm "OBRA and Clinical Services in the Drug Store" Searle Fellowship Program, 1991, now Dean, College of Pharmacy, Univ. of Tennessee. Honors Baccalaureate Thesis D. E. Wilcher, Sigma Xi Student Research Award (UGA) 1982, "Consultant Pharmacist Effect on Analgesic/Antiinflammatory Usage in a Geriatric LTCF," June, 1979. Undergraduate Research (1992-2001) 1. Angie Dellinger, Cancer Treatment in Nursing Facilities, 1992. 2. Dwayne Ragan, Nitroglycerin Usage in An LTCF, 1992. 3. Erica Veasley, H-2 Antagonist Utilization, 1992. 4. Sherry Yu, Calcium Channel Blockers Use in LTCF, 1992. 5. Carol Vandiver, Evaluation of Atrial Fibrillation Treatment in Nursing Hone Residents, 1992. 6. Tammy Gamble, Antitubercular Drug Use in Long Term Care, 1992. -57 -
7. Sara Boyd, Nitroglycerin Utilization in Nursing facility Patients, 1992. 8. Amy Willis, ACE Inhibitor DUR in an LTCF, 1994. 9. Christian Patterson, Bed Sore Treatments DUE in a SNF, 1994. 10. Kristie Cunningham, Antidepressant Drug Utilization in a Nursing Home, 1993. 11. Eric Chou, A DUR for Warfarin in Geriatric Paitents, 1993. 12. Kelli Pruett, Antiinfective DUR in LTCFs, 1993. 13. Sharon Youngblood, The Use of Pentoxyphylline in LTCFs, ,1993. 14. Laurie Wadsworth, DUR for Topical Glaucoma Treatment in an Intermediate Care facility, 1993. 15. Leslie Reynolds,Chronic Urinary Tract Antiinfectives DUR in an LTCF, 1993. 16. Karla Sanders, Nitroglycerin Patch DUE in a SNF, 1993. 17. Darla Daniel, DUR on Iron Supplementation in an LTCF, 1993. 18. David Mitchell, H-2 Antagonists Utilization in Nursing facility Residents , 1994. 19. Nick Lion, Pentoxyphylline Utilization in Long Term Care, 1994. 20. Micayle Williams, DUR for Sleep Medications in Nursing Homes, 1994. 21. Lee Turner, Thyroid Replacement Therapy in Nursing Facility Patients, 1994. 22. Steve Burch, Pain Medication Usage in LTC, 1994. 23. Julie Wunderlin, Parkinson Drug Treatment Evaluation in an ICF, 1994. 24. Meredith Potochnic, Cisapride and Metoclorpamide DUE in a SNF, 1994. 25. Mark Mullis, Warfarin vs. Aspirin in Post-Stroke Geriatric Patients, 1994. 26. Faith Malcolm, NTG Patch DUR in a SNF, 1994. 27. Stewart Bloodworth, Oral H-2 Antagonists Use in an ICF, 1994. 28. Vanessa Daves, Diuretic DUE in a Nursing Home, 1994. -58 -
29. Chris Lowry, The Use and Proper Dosing of Digoxin in Nursing Home Patients, 1994. 30. Amanda Reynolds, Oral H-2 Antagonists Use in a SNF, 1994. 31. Ann Butler, DUE for Topical Glaucoma Medications in an ICF, 1994. 32. Felicia Rosenblum, Calcium Channel Blockers DUR-Monitoring Guidelines and Side Effects in a Geriatric Population, 1994.
33. Cleve Tyre, Diabetic Medication Use in Nursing facility Patients, 1995. 34. Timothy Woodward, Antipsychotic Drug Use Evaluation for LTCFs, 1995. 35. Kennon Tyre, Chronic Urinary Tract Antiinfective Evaluation inan SNF, 1995. 36. Leslie Thompson, Benzodiazepine DUE for Nursing Facilities, 1995. 37. Carla Sumey, Agitation and Antipsychotics Effects in a SNF, 1995. 38. Dennis Sims, Digoxin Drug Utilizations Evaluation in an LTCF, 1995. 39. Polly Parker, HIgh Cholesterol Treatment in the Elderly, 1995. 40. Russell Prescott, Evaluation of theophylline therapy in the Management of COPD, Patients in a SNF,1995. 41. Tre Reinhardt, Pentoxyphylline DUR in a SNF, 1995. 42. Debra Boatner, Antiepileptic Drugs: Medication Utilization Evaluation, 1995. 43. Keith Enterkin, A Review of Angiotensin Converting Enzyme Inhibitor Use in the Treatment of Congestive Heart Failure Among Geriatric Nursing Home Patients, 1996. 44. David Vest, H-2 Antagonist Usage in a NF Population, 1996. 45. Beth Knight, Drug Utilization Review on Diabetic Medications,1996. 46. John Smith (deceased), Drug Utilization Review for Nitroglycerin in an LTCF, 1996. 47. Dustin Strickland, The Usefulness of Digoxin Serum Levels in the Control of Digoxin Therapy, 1996. 48. Scott Goodnight, Antiinfective Dosing and Renal Function in The Elderly, 1996. -59 -
49. Wes McConnell, DUR of Scheduled Acetaminophen in Frail Nursing Facility Patients, 1996. 50. Alec Mathis, DUR for Hypoglycemic Agents in LTC, 1996. 51. Ben Kelly, DUR for NF Hypnotic Medications, 1996. 52. Aimee McCrae, Nonaggressive short-term nutritional supplementation in a nursing home population, 1996 (see abstract no. 73 and research publication no. 91 above) 53. Laura Arons, Kim Crouse, Lisa England, Allison Gilmore, Mark Gilmore, Nick Patel, Osteoporosis Risk Assessment and Treatment in a Nursing Facility, 1996. 54. Bob Anderson, Kerry Matheny, Mark Novack, Chi Akoh, Raj Janampally, Evaluation of The Treatment of Depression and Dementia in A nursing Facility, 1997 (see abstract no. 82 above) 55. Charles Guerrero, Heath Gurr, Melissa McNab, Jeff Richardson, Evaluation of Secondary Prevention of Heart Attack and Stroke in A Nursing facility, 1997. 56. Lynne Beach, Tamara Crosby, Katherine Lucius, Jennifer McJunkin, Diabetes Mellitus Prevalence and Treatment Outcomes in a Geriatric Nursing Home Population, 1997. 57. Stacy Burke- Diabetes Education In Community Pharmacy -ACPE Proposal, 1997. 58. Stacey Bailey and Tanya McElheny, Fall Risk Analysis in a Nursing Home, 1998. 59. Lynne Beach, Deaths, Hospitalizations and Weight Changes in Diabetic vs. Non- Diabetic Patients in a Geriatric Nursing Home, 1998. 60. Kris Bedenbough, Stephen Heape, Heidi Howard, Ben King and Jay Lilly, NSAID Evaluation in Long-term Care, Summer 1998. 61. Jonathan Canterbury, Stephanie Dilliard, Deena Massengale, Billy Thurmon, Dee Dee Whiten, A A drug Utilization Evaluation on Possible Drug-Related Falls at ___Nursing
Home, fall 1998. 62. Russell Seagraves, James Jordan, Tara Thurmon, Michael Strange and Jason Wade, Falls and Psychoactive Drugs, Winter, 1999. 63. Bolaji Akindoju, Allison Budnick, Angela Jackson, Andrew Rains, and Angel Shinn, Falls in Nursing Home Residents: a retrospective study of fall risk in nursing home residents, Summer, 1999. -60 -
64. Megan Horner, Falls and Psychoactive Drug Load, Summer 1999-. 65. Lee Peeler, Jin Gao, Beth Holloman, Enrique Puertos, and Allison Swann. Polypharmacy evaluation in a Skilled nursing facility, fall, 1999. 66. Alan Campbell, Robert Marx, Trisha Owen, Suzanne Wagner, Suzie Slaughter, Pain Assessment in a skilled nursing facility, Spring, 2000. 67. Eric Erwin, Sarah Akbari, Larry Hill, Lynsey Bethel and Theresa Oluwasusi. Fall risk intervention results. Spring, 2000. 68. Emily McWhorter, Mellisa Odom, Jeff Goforth, DeeDee Waters. DUR of Depressive Symptom Assessment and Antidepressant Effectiveness, Fall, 2000. 69. Beth McGowan, Ski Williams, Chris Parker, Cardiovascular drug DUR in a LTCF, Spring, 2001. 70. Bob McWhorter, Meredith Harrison, Brant Razor, Josh Upton, Tommy Eades. Pain Assessment and treatment in a nursing facility. Summer, 2001. 71. Crystal Harrell. Amy Thompson, Shawn Nelson and Lawson Swint. Osteoporosis and fall risk assessment and treatment in a long-term care population. Fall, 2001. NOTE: 22 other students on group projects on similar topics from Winter 2002-Fall 2003. Post-Doctoral Students 1. S. Bayoumi, Ph.D., University of Cairo, 1971, "Hydergine Bioavailability", (with J.T. DiPiro). 1983-4. 2.M.J. Miller, Pharm.D., Philadelphia College of Pharmacy, 1984,"Transdermal Nitroglycerin Efficacy", (with W.G. Erwin). 3. Mark R. Morton, Pharm.D., Mercer, 1985. Merck Fellowship in Geriatric Drug Therapy, (with W. J. Spruill) 1985-1986. 4. Louise Mallet, Pharm.D., MCP 1980, Merck Fellow (with W.J.Spruill), 1986-87 and 1987-88 as ASHP Fellow. Grants, Funded Teaching, Research and Service Contracts and Awards- (>$1.4 M) Roche Hospital Pharmacy Award, 1974 (Research), $1,500, URI. Lederle Faculty Award, 1974, (Instruction) $500, URI. -61 -
National Science Foundation Research Assistant,1974, (Research) $1,500, URI. Teaching Effectiveness Grant, 1974, (Instruction), $500, URI. Joint Pharmacy-Medicine Clerkship, URI-Brown University Medical Sciences Program, 1975. (Instruction) $200,000, URI. (50%) Co-directed (with PL McKercher) Research for Keith P. Lewis selection for ASHP Research and Education Foundation Student Award, 1977, (Research) $1,000. URI
American Society of Hospital Pharmacists Research and Education Foundation Award with P. A. Frisk, and N.A. Campbell, 1978. (Research) $1,000, work done at URI and UGa. Athens General Hospital/Regional Medical Center Contract, 1978-92. (Service), $430,000, UGa. NOTE: Drs. William E. Wade and Charles Y. McCall provided the clinical services and 95% effort, JW Cooper, 5% administrative effort. UGa. Northeast Georgia Health District Hypertension Program Consultant Services Contract. 1979 - 1987. (Service) $40,000 NOTE: Drs. William E. Wade and Wynn W. Waite provided the services and 95% effort, JW Cooper, 5% administrative effort, UGa. Northeast Georgia Medical Center, Gainesville, Clinical Services and Education Program, Dr. Wynn Waite provided clinical services (Service) and 95% effort, JW Cooper, 5% adm. Effort, 1987-1989, $22,000, UGa. St. Mary's Hospital Co-Staffed Positions (2) Contract, 1979-92 (Service), $360,000. NOTE: Drs. George E. Francisco and William J. Spruill provided clinical services and 95% effort, JW Cooper, 5% administrative effort, UGa. Georgia Retardation Center Consultant Services Contract.1979-1986. (Service), $50,000. NOTE: JW Cooper, RB Brown and HH Cobb provided clinical services 95%. JW Cooper, 5% administrative effort over this period, UGa. Oconee-Oglethorpe Primary Care Center, Consultant Services Contract, 1981-3.(Service), $9,000. NOTE: JW Cooper provided both clinical and administrative effort, UGa. Co-directed Research (with JA Kotzan) for American Society of Consultant Pharmacist Research (ASCP) Paper Award, 1980. (Research), $500, UGa. Archambault Award for Contributions to Consultant Pharmacy, ASCP, (Research),1982, $1,000, UGa. Co-recipent of ASCP Contributed Paper Award (First place) (with L Pink and WR Francis). $500, 1983, UGa. -62 -
Recipient, ASCP Contributed Paper Award (First Place), 1984, $1,000. Ciba-Geigy, Inc., Potassium chloride dosage form comparision in nursing homes@, 1985 (Research), $1,500, UGa. Ciba-Geigy , Inc., "Trans-dermal nitroglycerin efficacy in geriatric long-term care patients," 1984. (Reserarch) $7,800, UGa. Ciba-Geigy. Inc. "Trans-dermal nitroglycerin efficacy comparision with other nitrate dosage Forms," 1984.(Research) $16,600., UGa.
Merck Research Foundation, Fellowship in Geriatric Pharmacy, 1984-6, $39,500, (Education and Research), UGa. Dow-Monsanto Co, Suloctidil efficacy in dementia,@ 1985, $90,000 (Research), UGa. American Cynamide/Lederle, Maxzide efficacy in geriatric patients, 1985, $9,600, (Research) ,UGa. Upjohn Co. Unrestricted Research Projects : $2,200, 1986; 1987, $2,500: 1988 , $1,700: 1989, $1,300;1990,$2,000: 1991, $2,800: 1992, $2,300, UGa. Glaxo Pharmaceuticals, Ranitidine Acceptance Study, 1987, $7,500, with MR Morton. (JW Cooper 10%), UGa. America Society of Hospital Pharmacists Research and Education Foundation, Geriatric Fellowship, $20,000, 1987 (Research and Education), UGa. Creative Research Award, University of Georgia Research Foundation, $1,000, 1987. Bristol Royal Health Care Trust, UK, Lecture Tour, Aug-Sep 1992, (Research and Education) $5,200, UGa. Manitoba Pharmacists Association, Canada, $3,000, 1993-1994, (Education and Service) Co-investigator, Valtrex Compliance Trial, Burroughs-Wellcome, (Research) $6,000, 1994, UGa. Miles Labs, Unrestricted Research Grant, $1,500, 1994, UGa. Colegio de farmaceuticos, Alicante,Spain, Lecture and Consultation tours, $12,500, (Education and Service) 1994, UGa. -63 -
Bristol-Myers Squibb (BMS), Unrestricted research grant, $5,000, 1995, UGa. BMS, Unrestricted research grant, $15,000, 1996, UGa. Pfizer labs, Unrestricted research grant, $10,000 1996, UGa. ASCP, The Peter Lamy Memorial Lecture, $1,000, 1999 APhA and HCQA. Pinnacle Award, $3,000, 2000. Travel Grant, $900 ASCP, Travel grant to May 2000 meeting, $800 ASCP Travel grant to November 2000 meeting, $1,144 ASHP, Travel grant to Midyear 2000 meeting, $500 Excerpta Medica, Travel grant to ASHP Midyear 2000, $500 Astra Zeneca, travel grant to American Heart Association Meeting, $800 Fick D, Waller J, Cooper JW, Wade WE. Potentially inappropriate medication use in the elderly: Updating and validation of the Beer’s Criteria, MCG/UGa Combined Intramural Grants Program, $20,375 (25%) APhA, travel grant to 2001 Meeting, $1200. ASCP, travel grant to 2001 spring meeting, $850. NCPA, travel grant to 2001 fall meeting, $900. ASCP, travel grant to fall 2001 meeting, $950. American College of Surgeons, 2001 meeting travel grant from Pharmacia, $1150. ASHP and Pharmacia, travel grants to Fall mid-year clinical meeting, $1625. Jowdy Professorship, Uga, 2002-3, $10,000. 2003-4, $10,000 ASCP, travel grant to receive Leadership in Education Award, 2009, $1,500 Returned to Sponsor
Cooper JW, Mallet L. Polycarbophil efficacy in geratric nursing facility patients with chronic constipation, $15,000 (Research), 1987, UGa. -64 -
Civic and Church Service President, Rolling Acres Homeowners Association, 1973-5. Coach, Watkinsville Little League, Basketball and Youth Football League, 1976-1983. Sons of The Revolution, Georgia Chapter, 1994-2007; Athens Chapter, 2008-. Vestryman, Chapel of St. John-The-Divine, Saunderstown, RI 1974-6.; Emmanuel Episcopal Church (EEC), Athens, GA., 1984-6. Church Sunday School Teacher (EEC), 1978-1984. Substitute Organist, St. Mary’s Chapel, Athens, 1970-72. Diocese of Atlanta, Lay Ministers Licenses Nos.21 (Lay Reader) and 32 (Chalice Bearer), St. Mary's Chapel, 1988; Emmanuel Church, Athens, GA. 1992-, Lay Eucharistic Minister (LEM) I, 1992-1999, LEM II, 1999-2000. Mentor, Education for Ministry Group, St. Gregory-The-Great, 1992-94 Member and Consultant to Homebound elderly, First United Methodist Church (FUMC) of Athens, 2000-, Consultant to Congregation of Israel Synagogue, 2003-, Consultant to Emmanuel Episcopal Church 1978-, First Baptist Church of Athens, 2008-, Catholic Student Center, 2008-, and Central Presbyterian Church, 2008-, Civic and University Support Founding member with wife, President's Club and Heritage Society, The University of Georgia. 1984- Board of Directors with wife, Friends of the Georgia Museum of Art, The University of Georgia. 1999-2002 Supporter with wife, UGa Performing Arts Center and Departments of Music and Art Scholarships, 2000- Athens Classic Center Patron, 2007- Athens Symphony Patron, 2007- UGa School of Music Director’s Circle, 2008- Hobbies- piano and golf.
Related Documents
![The Prairie [by James Fenimore Cooper] (Mini Discussion)](https://static.cupdf.com/doc/110x72/55894f80d8b42a49328b4757/the-prairie-by-james-fenimore-cooper-mini-discussion.jpg)
